Section 33

EurekaMag Full Text Articles Chapter 32,999


French, C.C.J. 1991: Prospects for the reduction of noxious emissions from diesel vehicles and the role of alternative fuels and power sources. Kroon, M , R Smit And J Van Ham (Ed ) Studies in Environmental Science, 45 Freight Transport And The Environment Xiii+355p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York, Usa) Illus Maps 93-97
Robertson, I.H.; Halligan, P.W.; Marshall, J.C. 1993: Prospects for the rehabilitation of unilateral neglect. Robertson, I H, Marshall, J C Brain Damage, Behaviour and Cognition Series; Unilateral neglect: Clinical and experimental studies 279-292
Cai, Z. 1993: Prospects for the research on soil trace gases. Acta Pedologica Sinica 30(2): 117-124
Scheibling, R.; Hatcher, B. 1994: Prospects for the sea urchin fishery off the Atlantic coast of Nova Scotia Boom or bust. Canadian Manuscript Report of Fisheries and Aquatic Sciences 1994(2247): 95
Sorokin, N.N. 1991: Prospects for the study of mosquito sensitivity to insecticides. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 2: 57-59
Darby, G. 1990: Prospects for the therapy of hiv. Revista de Farmacologia Clinica y Experimental 7(3): 177-184
Proietto, J. 1992: Prospects for the treatment of obesity. Medical Journal of Australia 157(6): 363-364
Ellis, S.G.; Bates, E.R.; Schaible, T.; Weisman, H.F.; Pitt, B.; Topol, E.J. 1991: Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis. Journal of the American College of Cardiology 17(6 Suppl B): 89b-95b
Yakovleva, S.S. 1991: Prospects for the use of dihydromonocalcium phosphate for the prevention and treatment of chronic fluorine poisoning. Gigiena Truda i Professional'nye Zabolevaniya (2): 28-29
Korytnikov, K.I. 1990: Prospects for the use of doppler echocardiography in the diagnosis of mitral valve disease. Klinicheskaya Meditsina 68(8): 98-102
Alekseichuk, V.S.; Petrunin, D.D.; Lopukhin, Y.M. 1991: Prospects for the use of extracorporeal immunoadsorption in the multimodality treatment of aids. Immunologiya 3: 17-21
Jana, B.; Sobczak, J. 1991: Prospects for the use of gonadotropin releasing hormone in the reproduction of cows. Medycyna Weterynaryjna 47(10): 469-471
Vlasov, Y.G.; Miloshova, M.S.; Medvedev, A.M. 1992: Prospects for the use of ionometry in the analysis of agricultural objects. Izvestiya Timiryazevskoi Sel'skokhozyaistvennoi Akademii 1992(3): 170-174
Levin, G.M. 1990: Prospects for the use of neoteny in plant growing. Izvestiya Akademii Nauk Turkmenskoi SSR Seriya Biologicheskikh Nauk 2: 3-9
Berdov, B.A.; Skorapod, V.Yu 1991: Prospects for the use of radiation therapy to improve treatment results in colon cancer patients. Meditsinskaya Radiologiya 36(1): 54-56
Mcclure, N.C.; Weightman, A.J. 1992: Prospects for the use of selected xenobiotic-degrading and genetically engineered microorganisms in the treatment of chemical wastes. Fry, J C, Day, M J Plant and Microbial Biotechnology Research Series; Release of genetically engineered and other micro-organisms: 24-39
Chakalova, E.S. 1989: Prospects for the use of the in vitro cultivation method at the botanical institute and garden of the bulgarian academy of sciences. Fitologija 37: 79-83
Douglas, G.R.; Jiao, J.; Gingerich, J.D.; Soper, L.M. 1997: Prospects for the use of transgenic mouse models to assess germ line risk from chemicals. Mutation Research 379(1 Suppl 1): S88
Sivkov, I.I.; Chebyshev, N.S.; Kuznetsov, A.B.; Godin, V.A. 1991: Prospects for the use of valsalvas test in the diagnosis of left ventricular dysfunction in coronary heart disease. Sovetskaya Meditsina 3: 57-60
Raccah, B.; Gal, O.A.; Antignus, Y. 1991: Prospects for the use of virus genes to control vector borne virus epidemics. Phytoparasitica 19(4): 347
Aresta, M.; Quaranta, E.; Tommasi, I. 1992: Prospects for the utilization of carbon dioxide. Energy Conversion and Management 33(5-8): 495-504
Sacktor, N.; McArthur, J. 1997: Prospects for therapy of HIV-associated neurologic diseases. Journal of Neurovirology 3(2): 89-101
Morris, P.J. 1989: Prospects for transplantation. Melchers, F (Ed ) Progress in Immunology, Vol Vii; 7th International Congress Of Immunology, Berlin, West Germany, Ci+1318p Springer-Verlag New York, Inc : Secaucus, New Jersey, Usa; Berlin, West Germany Illus 1155-1162
Robbins, P.D.; Evans, C.H. 1996: Prospects for treating autoimmune and inflammatory diseases by gene therapy. Gene Therapy 3(3): 187-189
Rangan, U.; Bulkley, G.B. 1993: Prospects for treatment of free radical-mediated tissue injury. British Medical Bulletin 49(3): 700-718
Ang, E.S.; Sundram, F.X. 1993: Prospects for tumour imaging with radiolabelled antibodies. Annals of the Academy of Medicine Singapore 22(5): 776-784
Collins, M.K.; Patel, P.; Flemming, C.L.; Eccles, S.A. 1992: Prospects for tumour therapy using gene transfer. Bone Marrow Transplantation 9(Suppl 1): 171-173
Foege, W.H. 1989: Prospects for universal immunization: strategies for achievement. Reviews of Infectious Diseases 11(Suppl 3): S659-S662
O'hanley, Peter 1996: Prospects for urinary tract infection vaccines. Mobley, H L T, Warren, J W Urinary tract infections: Molecular pathogenesis and clinical management 405-425
Nam, E.A. 1993: Prospects for use of entomopathogenic fungi in biological control of bloodsucking Diptera. Entomological Review 71(8): 70-72
Jessup, J.M.; Goodwin, T.J.; Spaulding, G. 1993: Prospects for use of microgravity-based bioreactors to study three-dimensional host-tumor interactions in human neoplasia. Journal of Cellular Biochemistry 51(3): 290-300
Struthers, A.D. 1995: Prospects for using a blood sample in the diagnosis of heart failure. Qjm: Monthly Journal of the Association of Physicians 88(5): 303-306
Zilova, I.S.; Vysotskii, V.G.; Kon'kova S.V. 1989: Prospects for using alfalfa as a source of food protein. Voprosy Pitaniia 48: 12-19
Kabachnyi, P.I. 1990: Prospects for using amylolytic enzyme inhibitors to treat carbohydrate metabolism disturbances. Farmatsevtychnyi Zhurnal (Kiev) (4): 31-37
Maksyutina, N.P.; Vetyutneva, N.A.; Nazarenko, A.Yu; Mitchenko, F.A. 1991: Prospects for using crown ethers for the extraction photometric determination of alkaline metals in drugs. Farmatsiya (Moscow) 40(3): 75-78
Krylov, Y.F.; Lyubimov, I.B.; Mulyar, A.G. 1991: Prospects for using eicosapentaenoic and docosahexaenoic acids as drugs. Khimiko-Farmatsevticheskii Zhurnal 25(9): 4-10
Mamontov, A.S.; Rykov, V.I.; Pavlov, M.Yu 1990: Prospects for using helium neon lasers to treat postoperative purulent complications in oncological patients. Sovetskaya Meditsina 3: 37-42
Evtushenko, N.S.; Kudryavtseva, M.P. 1989: Prospects for using high performance liquid chromatography for the analysis of aminoglycoside antibiotics. Farmatsiya 38(1): 76-80
Soboleva, S.V. 1990: Prospects for using lactoglobulins with specific action to treat infants with acute intestinal infections and dysbacteriosis. Pediatriya (Moscow) (11): 48-51
Khmelevskaya, S.S.; Zhoglo, F.A.; Mukhailyk, O.M.; Bibik, S.M.; Pavlichko, S.S.; Fetsych, L.T.; Matviichuk, O.Ya 1989: Prospects for using modern forms of stomatological drugs. Farmatsiya 38(1): 14-18
Apfel, S.C. 1995: Prospects for using neurotrophic factors in the treatment and prevention of neurotoxicity An overview. Neurotoxicology (Little Rock) 16(3): 538
Ushmorov, A.G. 1990: Prospects for using nonsteroid antiinflammatory drugs in the treatment of malignant neoplasts. Voprosy Onkologii (St Petersburg) 36(10): 1163-1170
Bunyatyan, A.A.; Shitikov, I.I.; Flerov, E.V. 1991: Prospects for using pulse oximetry in anesthesiology and resuscitation. Anesteziologiya i Reanimatologiya 1: 3-7
Broun, I.I.; Goncharov, N.I.; Kirik, I.I.; Mirochnik, O.Yu; Pushenko, M.Ya; Severina, I.I.; Skulachev, V.P. 1990: Prospects for using salt and alkali tolerant cyanobacteria in technological bioenergetics. Izvestiya Akademii Nauk SSSR Seriya Biologicheskaya 3: 465-469
Sharkey, R.M.; Blumenthal, R.; Goldenberg, D.M. 1992: Prospects for using the anti antibody second antibody method in radioimmunotherapy. Proceedings of the American Association for Cancer Research 33: 341
Moshkova, L.V. 1989: Prospects for using the automatic information retrieval system lekarstov pharmaceutical information service. Farmatsiya 38(1): 11-13
Levin, G.M. 1990: Prospects for using the neoteny phenomenon in plant growing. Izvestiya Akademii Nauk Turkmenskoi SSR Seriya Biologicheskikh Nauk 3: 59-62
Whitley, R.J. 1993: Prospects for vaccination against herpes simplex virus. Pediatric Annals 22(12): 726; 729-732
Ada, G.L. 1992: Prospects for vaccination at mucosal surfaces for the control of sexually transmitted diseases. Quinn, T C (Ed ) Advances in Host Defense Mechanisms, Vol 8 Sexually Transmitted Diseases Xi+340p Raven Press: New York, New York, Usa Illus 275-290
Horwitz, M.A.; Marston, B.J.; Broome, C.V.; Breiman, R.F. 1993: Prospects for vaccine development. Barbaree, J M, Breiman, R F, Dufour, A P Legionella: Current status and emerging perspectives: 296-297
Smith, W.D. 1996: Prospects for vaccines against gastrointestinal helminth parasites of ruminants. Bovine Practitioner 1996(30): 28-31
Fischer, G.W.; Ottolini, M.G.; Mond, J.J. 1997: Prospects for vaccines during pregnancy and in the newborn period. Clinics in Perinatology 24(1): 231-249
Flotte, T.R. 1993: Prospects for virus-based gene therapy for cystic fibrosis. Journal of Bioenergetics and Biomembranes 25(1): 37-42
Garcez,L.M.; Chagas,A.P.; Gomes,P.A.F.; Cardoso,J.F.; Miranda,J.F.C.; Dickson,L.A.J.; Mota,E.F.; Bezerra,L.M.; FraihaNeto,H.; Quinnell,R.J.; Courtenay,O. 2008: Prospects for visceral leishmaniasis control in Amazonian municipalities. Revista Da Sociedade Brasileira De Medicina Tropical: Suplemento Iii, 95-96
Kyeyamwa,H.; Verbeke,W.; Huylenbroeck,G.van 2008: Prospects for voluntary group marketing of livestock in rural Uganda an empirical assessment of farmers attitudes and intentions. Outlook On Agriculture: 3, 177-184
Dorling, A.; Lechler, R.I. 1994: Prospects for xenografting. Current Opinion in Immunology 6(5): 765-769
Viacava, E. 1991: Prospects in cancer prevention. Prensa Medica Argentina 78(6): 239-246
Taylor, S.H. 1991: Prospects in heart failure attractions of the concept of vasodilation by dopaminergic stimulation. American Journal of Noninvasive Cardiology 5(Suppl 1): 2-5
Prieur, A.M. 1993: Prospects in pediatric rheumatology. Journal of Rheumatology. Suppl 37: 2-4
Cheredeev, A.N. 1995: Prospects in the development of laboratory immunological service. Klinicheskaya Laboratornaya Diagnostika 1995(6): 76-78
Byelikov, V.H. 1989: Prospects in the development of pharmaceutical science. Farmatsevtychnyi Zhurnal (Kiev) (6): 32-35
Riba, G.; Silvy, C. 1991: Prospects in the microbial control of agricultural insect pests. Bulletin de la Societe Zoologique de France Evolution et Zoologie 116(3-4): 331-338
Hallet, S.; Gregoire, J.C.; Coremans Pelseneer, J. 1994: Prospects in the use of the entomopathogenous fungus Beauveria bassiana Vuill to control the spruce bark beetle Ips typographus L. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 59(2A): 379-383
Morris, P.J. 1991: Prospects in transplantation. Transplantation Proceedings 23(4): 2133-2137
Shah,N.C. 2008: Prospects of Ethnobotany in India. Ethnobotany: 1 2, 16-24
Esparza, J. 1998: Prospects of HIV preventive vaccine development. Medicina (Buenos Aires) 58(Suppl 1): 57-63
Melief, C.J. 1993: Prospects of T-cell immunotherapy for cancer by peptide vaccination. Seminars in Hematology 30(3 Suppl 3: 32-33
Singh-Naz, N.; Rodriguez, W.J.; Pedreira, F. 1990: Prospects of a rotavirus vaccine. Pediatric Annals 19(12): 727-731
Stagni, G.; Francisci, D.; Carotti, A. 1992: Prospects of active prophylaxis of viral exanthems The vaccination against varicella. Giornale di Malattie Infettive e Parassitarie 44(4): 302-309
Trainin, N. 1990: Prospects of AIDS therapy by thymic humoral factor, a thymic hormone. Natural Immunity and Cell Growth Regulation 9(3): 155-159
Ponce De Leon E.; Martinez E.; Beruff A.; Martinez G.; De Vales M.J.; Valdez L.; Gonzalez R. 1992: Prospects of an expert system for the diagnosis of several alcoholic states. Revista Espanola de Drogodependencias 17(1): 45-48
Nicholas, F.W. 1994: Prospects of animal genetics. Animal Genetics 25(Suppl 2): 8
Tikchonenko, T.I.; Miroshnichenko, O.I.; Borisenko, A.S.; Ponomareva, T.I.; Ernst, L.K. 1991: Prospects of antiviral immunity in transgenic animals with antisense rna genes. Acta Microbiologica Hungarica 38(3-4): 173
Tomanov, I.S.; Tkachev, S.I.; Matyakin, E.G.; Alferov, V.S.; Zak, E.M. 1998: Prospects of application of a hyperthermia for nonresectable cervical lymph node metastases of head and neck cancer. British Journal of Cancer 77(Suppl 1): 35
Kozireva, S.; Murovska, M. 1992: Prospects of applying transgenic animals in biology and medicine. Latvijas Zinatnu Akademijas Vestis B Dala Dabaszinatnes 1992(8): 53-58
Cheunbarn,T.; Cheunbarn,S.; Khumjai,T. 2008: Prospects of bacterial granule for treatment of real textile industrial wastewater. International Journal Of Agriculture And Biology: 6, 689-692
D.K.ning, G.J.M.; Lemstra, P.J. 1993: Prospects of bacterial poly. Abstracts of Papers American Chemical Society 206(1-2): AGFD 161
Pawar, V.M.; Thombre, U.T. 1992: Prospects of baculoviruses in integrated pest management of pulses. Ananthakrishnan, T N Emerging trends in biological control of phytophagous insects: 165-171
Singh, I.; Mittal, V.K. 1993: Prospects of biogas as dual fuel in small diesel engines. Journal of Research Punjab Agricultural University 29(2): 230-240
Diehl,H.A. 2008: Prospects of biological and physical energy sources. Bulletin Of University Of Agricultural Sciences And Veterinary Medicine Cluj Napocal Science And Biotechnologies: 1 2, 1-2
Lukezic, F.L.; Latch, G.C.M.; Hay, F.S.; Sivasithamparam, K. 1996: Prospects of biological control of diseases in pasture crops. Chakraborty, S, Leath, K T, Skipp, R A, Pederson, G A, Bray, R A, Latch, C M, Nutter, F W, Jr Pasture and forage crop pathology: 509-531
Pelz, H.J. 1996: Prospects of biological control of rodents. Mitteilungen aus der Biologischen Bundesanstalt für Land- und Forstwirtschaft Berlin-Dahlem: 370
Spada,V.; Dipaola,M. 2008: Prospects of biomass energy use in Apulia. Journal Of Commodity Science, Technology And Quality: 1 4, 67-88
Glanzmann, C. 1994: Prospects of chemo- and immunotherapy in combined treatment of solid tumours in adult patients. Amaldi, U, Larsson, B International Congress Series; Hadrontherapy in oncology 20-32
Starzl, T.E.; Tzakis, A.; Fung, J.J.; Todo, S.; Demetris, A.J.; Manez, R.; Marino, I.R.; Valdivia, L.; Murase, N. 1994: Prospects of clinical xenotransplantation. Transplantation Proceedings 26(3): 1082-1088
Goebell, H.; Layer, P. 1989: Prospects of conservative therapy in acute pancreatitis developments from 1981 1989. Internist 30(11): 718-724
Frasch, A.C.; Sánchez, D.O.; Cazzulo, J.J. 1990: Prospects of defined proteins for vaccine development. Memorias do Instituto Oswaldo Cruz 85(4): 523-529
Mel'nikov, N.N.; Kozlov, V.A. 1996: Prospects of developing and producing native herbicides. Agrokhimiya (6): 74-80
Moodbidri, S.B.; Vange, G.R.; Mehta, P.B.; Iyer, K.S. 1998: Prospects of developing human seminal plasma inhibin as a male immunocontraceptive. American Journal of Reproductive Immunology 40(4): 252
Vespalec, R.; Sustacek, V.; Bocek, P. 1993: Prospects of dissolved albumin as a chiral selector in capillary zone electrophoresis. Journal of Chromatography 638(2): 255-261
Messmer, K. 1990: Prospects of experimental surgery. Chirurg 61(4): 248-250
Rozenzweig,E.; Aksyonova,E.A.; Milash,S.B.; Goloenko,D.V.; Davydenko,O.G. 2008: Prospects of exploiting of photoperiod sensitivity gene E7 in early soybean breeding and revealing of its sources with SSR-markers. Soybean Genetics Newsletter: , 1-7
Casabianca, F.; Fallola, A. 1994: Prospects of extensive pig breeding in the Mediterranean region and commodity chain management Specialization of breeding by the quality of processed products. Gibon, A , Flamant, J C EAAP Publication; The study of livestock farming systems in a research and development framework 61-73
Takeda, Y. 1992: Prospects of fetal treatment. Clinical Gynecology and Obstetrics 46(3): 344-345
Khurana,S.M.P.; Chakrabarti,S.K. 2008: Prospects of gene revolution in India for sustainable agricultural development. Agriculture For Food Security And Rural Growth: 39
Steinberg, M.H. 1991: Prospects of gene therapy for hemoglobinopathies. American Journal of the Medical Sciences 302(5): 298-303
John, M.E. 1994: Prospects of genetically engineering cotton for value-added fibers. Abstracts of Papers American Chemical Society 207(1-2): BTEC 123
Ploeger, C. 1989: Prospects of gerbera. Acta Horticulturae 248: 69-74
Bechelli, L.M. 1993: Prospects of global elimination of leprosy as a public health problem by the year 2000. International Journal of Leprosy and Other Mycobacterial Diseases 61(4 Suppl): 44A
Isakov, V.I.; Kushniruk, V.A. 1967: Prospects of increasing coal reserves and recovery in the Lvov-Volyn basin. Geologiya i Geokhimiya Goryuchikh Iskopayemykh 11: 15-20
Abedin, M.Z.; Hossain, M.A. 1991: Prospects of increasing pulses production through improved cropping systems. Sahni, B B And U Raman (Ed ) Advances in Pulses Research in Bangladesh; Second National Workshop on Pulses, Joydebpur, Bangladesh, June 6-8, 1989 Xi+254p Icrisat (International Crops Research Institute For The Semi-Arid Tropics): Patancheru, Andhra Pradesh, India Illus Paper 65-74
Sumathi,P.; Rathakrishnan,T. 2008: Prospects of indigenous practices for promoting sustainable farming in dryland agriculture. Agriculture Update: 3 4, 398-401
Chantraine, A.; Mahler, F. 1996: Prospects of knee injuries in soccer players. Saillant, G, SOFCOT Continuing Education Collection; Surgical pathology of the knee in athletes, Cahiers d'Enseignement de la SOFCOT; Pathologie chirurgicale du genou du sportif: 202-207
Paulson, J.C. 1990: Prospects of large scale enzymatic synthesis of sialosides. Abstracts of Papers American Chemical Society 199(1-2): CARB 61
Lone,M.A.; Saxena,R.C.; Srivastava,P.N.; Lone,M.A.; DinishaMalviya 2008: Prospects of medicinal plants as natural remedies in langate block of Kupwada district of Jammu and Kashmir. Flora And Fauna (jhansi): 2, 355-358
Lakhanpal, T.N. 1994: Prospects of mushrooms from the wild. Nair, M C Advances in mushroom biotechnology 15-22
Chen, S.; Yu, Z. 1992: Prospects of myocardial ischemia-reperfusion injury investigation. Zhonghua Xin Xue Guan Bing Za Zhi 20(2): 75
Lomanov, M.F. 1991: Prospects of nuclear medicine application for proton radiation therapy. European Journal of Nuclear Medicine 18(8): 602
Park, K. 1998: Prospects of organ sharing and strategies for increasing transplants in Asia. Transplantation Proceedings 30(7): 3647
SukhbirSingh; Verma,H.N.; Vatsa,D.K. 2008: Prospects of paddy cultivation mechanization in hills of Himachal Pradesh. Ama, Agricultural Mechanization In Asia, Africa And Latin America: 3, 46-49
Abel Smith, B. 1989: Prospects of paying for scientific advances. Bloom, B R And A Cerami (Ed ) Annals Of The New York Academy Of Sciences, Vol 569 Biomedical Science And The Third World: Under The Volcano; Conference, New York, New York, Usa, October 18-20, 1988 Xx+335p New York Academy Of Sciences: New York, New York, Usa Illus Maps 311-317
Ohura, K. 1994: Prospects of pharmacological education in its relationship with education in dentistry. Japanese Journal of Pharmacology 64(Suppl 1): 23P
Spence, A.M.; Rasey, J.S. 1991: Prospects of radioprotection of the nervous system. Gutin, P H , S A Leibel And G E Sheline (Ed ) Radiation Injury to The Nervous System Xiv+482p Raven Press: New York, New York, Usa Illus 431-454
LiXiuJuan; LiHong; HuangRenZheng; ZhaoJian 2008: Prospects of research and exploitation of resources of Guangxi wild flower lily. Journal Of Hunan Agricultural University: 4, 442-449
Adiga, P.R. 1998: Prospects of riboflavin carrier protein as an antifertility vaccine in male and female mammals. American Journal of Reproductive Immunology 40(4): 251
Maksimaw, Y.L.; Kamano, M.F. 1995: Prospects of scientifically based individual sexual selection in cattle breeding. Vyestsi Akademii Ahrarnykh Navuk Byelarusi 1995(1): 40-43
Timofeeva, M.A.; Maliuchenko, N.V.; Kulikova, M.A.; Shleptsova, V.A.; Shchegolkova, Y.A.; Vediakov, A.M.; Tonevitsky, A.G. 2008: Prospects of studying the polymorphisms of key genes of neurotransmitter systems II The serotonergic system. Human Physiology 34(3): 363-372
Chernova, O.V. 1995: Prospects of the Red Book of Russian natural soils. Pochvovedenie 1995(4): 514-519
Bakketeig, L.S.; Goldenberg, R.L.; Hoffman, H.J. 1997: Prospects of the collaborative small-for-gestational-age birth study for the five year old follow-up study. Acta Obstetricia et Gynecologica Scandinavica. Suppl 165: 102-103
Hueppe, J.; Pott, R. 1993: Prospects of the development of modern agricultural landscapes considering palaeoecological aspects. Zeitschrift fur Kulturtechnik und Landentwicklung 34(4): 233-242
Endo, T. 1994: Prospects of the drug delivery systems. Journal of the Japan Pharmaceutical Association 46(6): 803-809
Hibst, R.; Keller, U. 1991: Prospects of the erbium yag laser in dentistry. Lasers in Surgery and Medicine (Suppl 3): 17-18
Sokolov,V.A. 2008: Prospects of the forestry development in Siberia. Contemporary Problems Of Ecology: 3, 289-294
Sehnal,F. 2008: Prospects of the practical use of silk sericins. Entomological Research: Suppl
LuoYongMing 2008: Prospects of the research on biochemical processes, quality evolvement and risk management of soil environment. Acta Pedologica Sinica: 5, 846-851
Nassar,A.M.; Rudorff,B.F.T.; Antoniazzi,L.B.; Aguiar,D.A.; Bacchi,M.R.P.de; Adami,M. 2008: Prospects of the sugarcane expansion in Brazil impacts on direct and indirect land use changes. Sugarcane Ethanol: Contributions To Climate Change Mitigation And The Environment: 93
Khapkin, I.S. 1994: Prospects of the usage of plant preparations for the regulation of the aggregational state of blood. Rastitel'nye Resursy 30(1-2): 86-90
Rasnitsyn, S.P.; Lebedeva, N.N. 1996: Prospects of the use of attractants for mosquito control. Entomological Review 75(3): 82-91
Sirvydis, V. 1990: Prospects of the use of enzyme preparations in industrial poultry farming. Eksperimentine Biologija 4: 21-30
Estrada Martinez, M.E.; Cruz, T.E.M. 1991: Prospects of the use of the entomopathogenic fungus Beauveria bassiana Vuill in the biological control of Diatraea saccharalis. Pavis, C , Kermarrec, A INRA Colloquia; Caribbean meetings on biological control Colloques de l'INRA; Caribbean meetings on biological control : 359-370
Doroshenko, N.D.; Pokhil'chenko I.N. 1989: Prospects of the use of the vapor phase method for determining ethylene bisdithiocarbamates in plant parts. Agrokhimiya (9): 116-118
Kormis, K.K.; Wu, G.Y. 1995: Prospects of therapy of liver diseases with foreign genes. Seminars in Liver Disease 15(3): 257-267
Underwood, L.E.; Clemmons, D.R. 1994: Prospects of therapy with IGF-I for catabolic conditions. Baxter, R C, Gluckman, P D, Rosenfeld, R G International Congress Series; The insulin-like growth factors and their regulatory proteins 449-456
Lindvall, O. 1991: Prospects of transplantation in human neurodegenerative diseases. Trends in Neurosciences 14(8): 376-384
Tabassum,N.; Uddin,M.R.; Gim,U.S. 2008: Prospects of triticale as fodder and feed in farming of Bangladesh. Multifunctional Grasslands In A Changing World, Volume Ii: Xxi International Grassland Congress And Viii International Rangeland Congress, Hohhot, China, 29 E 5 Y: 6
Djaenudin,D.; Hendrisman,M. 2008: Prospects of upland food crops development in Merauke regency. Jurnal Penelitian Dan Pengembangan Pertanian: 2, 55-62
Shmeleva, E.A.; Vartanian, R.V.; Aleshkin, V.A.; Paramonova, I.Aq.; Baturina, i.G.; Malyshev, N.A. 2008: Prospects of use coryneformic bacteria drug to prevent and treat respiratory infections. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 2008(3): 12-16
Sattar,M.A.; Rahman,M.F.; Das,D.K.; Choudhury,A.T.M.A. 2008: Prospects of using Azotobacter, Azospirillum and cyanobacteria as supplements of urea nitrogen for rice production in Bangladesh. Aciar Proceedings Series: 0, 59-66
Abramchenko, V.V.; Kostyushkov, Y.V.; Tyaptin, A.A.; Izyumtsev, I.S.; Popov, I.N.; Volchek, I.V. 1993: Prospects of using antioxidants in prophylaxis of gestosis among workers who have contact with epichlorohydrin. Reproductive Toxicology 7(5): 489
Adamyan, L.V.; Fanchenko, N.D.; Andreeva, E.N.; Novikov, E.A.; Alekseeva, M.L. 1990: Prospects of using cancer antigen as markers of gynecological diseases. Sovetskaya Meditsina 6: 26-29
Shumkov, M.A.; Nagornyi, S.A. 1993: Prospects of using juvenile Tilapia in biological mosquito control. Meditsinskaya Parazitologiya i Parazitarnye Bolezni 1993(3): 43-45
Das, S.; Ward, L.R.; Burke, C. 2008: Prospects of using marine actinobacteria as probiotics in aquaculture. Applied Microbiology and Biotechnology 81(3): 419-429
Mwangi, E.N.; Kaaya, G.P. 1997: Prospects of using tick parasitoids for tick management in Africa. International Journal of Acarology 23(3): 215-219
Chiang, B.L.; Ansari, A.; Gershwin, M.E. 1992: Prospects of vaccination in autoimmune diseases. International Archives of Allergy and Immunology 98(3): 181-188
Williams, P.E.; Thompson, R.A. 1993: Prospects of vaccine therapy for HIV infection. Immunologia Polska 17(4): 327-342, 1992
Dupont, P. 1993: Prospects of vegetation mapping following the publication of a partial atlas of French flora. Gaussenia 8: 25-27
Himri,Y.; Stambouli,A.B.; Draoui,B. 2008: Prospects of wind farm development in Algeria. American Journal Of Environmental Sciences: 6, 589-594
Labdi, M.; Bousnad, Z.; Solh, M.M.B.; Wery, J. 1990: Prospects of winter chickpea in algeria. Walby, B J And S D Hall (Ed ) Chickpea in The Nineties; Second International Workshop on Chickpea Improvement, Patancheru, Andhra Pradesh, India, December 4-8, 1989 Vii+403p Icrisat (International Crops Research Institute For The Semi-Arid Tropics): Patancheru, Andhra Pradesh, India; Icarda (International Center For Agricultural Research in The Dry Areas): Aleppo, Syria Illus Paper 287-288
Borgo, R.; Souty Grosset, C.; Gomot, L. 1996: Prospects offered by the study of mitochondrial DNA in snails of the genus Helix. Bulletin de la Societe Zoologique de France Evolution et Zoologie 121(1): 137-138
Sisken, B.F.; Walker, J.; Orgel, M. 1993: Prospects on clinical applications of electrical stimulation for nerve regeneration. Journal of Cellular Biochemistry 51(4): 404-409
Chiran,A.; Drobota,B.; Gindu,E. 2008: Prospects on the world cereal market. Cercetari Agronomice In Moldova: 1, 79-87
Bougle, D.; Chincholle, R. 1995: Prospects opened by radiopasteurization to farm products and specially milk products. Comptes Rendus de l'Academie d'Agriculture de France 81(1): 39-52
Hosobuchi, K. 1992: Prospects radiation sterilization of medical devices. Radioisotopes 41(5): 273-279
Samyn, G.; Wojdyla, A. 1994: Prospects to the use of culture filtrates for the selection of bromeliads resistant to Fusarium oxysporum. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 59(4A-B): 2503-2505
Szabo,L'.; Grznar,M. 2008: Prosperity factors of agricultural companies in the SR in the LFA after the EU integration. Zemedelska Ekonomika (agricultural Economics): 10, 461-466
Kamiya, A.; Kakinuma, S.; Onodera, M.; Miyajima, A.; Nakauchi, H. 2008: Prospero-related homeobox 1 and liver receptor homolog 1 coordinately regulate long-term proliferation of murine fetal hepatoblasts. Hepatology 48(1): 252-264
Feruglio Egidio 1956: Prospetto dei terreni quaternari dell Argentina. Pages 939-941 1956
Benenson, E.V.; Beĭshenov, A.D.; Nemtsov, B.F.; Kurmanalieva, A.K. 1990: Prospidin in the treatment of rheumatoid arthritis. Revmatologiia 3: 44-48
Samsonov, V.A.; Mazina, N.M.; Gorshkova, N.I. 1991: Prospidine and leakadin in multimodality treatment of kaposi sarcoma patients. Vestnik Dermatologii i Venerologii 8: 84
Mapp, C.E.; Fabbri, L.M.; Boniotti, A.; Maggi, C.A. 1991: Prostacyclin activates local peptide release from capsaicin sensitive afferents in guinea pig bronchi through a ruthenium red sensitive pathway. American Review of Respiratory Disease 143(4 Part 2): A756
Kowala, M.; Mazzucco, C.; Hartl, K.; Seiler, S.; Warr, G.; Abid, S.; Grove, R. 1993: Prostacyclin agonists reduce atherosclerosis by suppressing monocyte-macrophage activity and cytokine production. FASEB Journal 7(3-4): A638
Li, Z.; Lee, H.; Bielefeldt, K.; Chapleau, M.W.; Abboud, F.M. 1995: Prostacyclin analog carbacyclin inhibits CA-2+-activated K+ current in cultured baroreceptor neurons. Society for Neuroscience Abstracts 21(1-3): 1831
Nicolini, F.A.; Nichols, W.W.; Mehta, J.L. 1989: Prostacyclin analog iloprost decreases thrombolytic potential of t pa in canine coronary thrombosis. Circulation 80(4 Suppl 2): II234
Mickelson, J.K.; Cronin, M.; Lee, K.; Almassey, S.; Lucchesi, B.R. 1990: Prostacyclin analog maintains blood flow despite intracoronary thrombus formation in a canine model. Journal of the American College of Cardiology 15(2 Suppl A): 86A
Kamio, K.; Sato, T.; Liu, X.; Sugiura, H.; Togo, S.; Kobayashi, T.; Kawasaki, S.; Wang, X.; Mao, L.; Ahn, Y.; Holz, O.; Magnussen, H.; Rennard, S.I. 2008: Prostacyclin analogs stimulate VEGF production from human lung fibroblasts in culture. American Journal of Physiology. Lung Cellular and Molecular Physiology 294(6): L1226-L1232
Sprague, R.S.; Bowles, E.A.; Hanson, M.S.; DuFaux, E.A.; Sridharan, M.; Adderley, S.; Ellsworth, M.L.; Stephenson, A.H. 2008: Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes. Microcirculation 15(5): 461-471
Shibasaki, M.; Takahashi, A.; Aoki, T.; Kogi, K.; Nishimiya, Y.; Nara, T.; Yamaguchi, T. 1989: Prostacyclin analogue and blood circulation improving agent and anti ulcer composition containing it as active ingredient us patent 4837342 june 6 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(1): 527
Feoktistov, I.; Biaggioni, I. 1994: Prostacyclin and PGE-1 receptors increase cytoplasmic Ca-2+ in human erythroleukemia cells through distinct G-proteins. Clinical Research 42(2): 332A
Fredrich, M.; Mueller, B. 1992: Prostacyclin and atherosclerosis. Rubanyi, G M, Vane, J International Congress Series; Prostacyclin: New perspectives for basic research and novel therapeutic indications: 169-180
Blitstein Willinger, E. 1996: Prostacyclin and carbacyclin derivatives as agents for the treatment of multiple sclerosis. Official Gazette of the United States Patent and Trademark Office Patents 1185(2): 1216
Helleboid, L.; Katami, M.; Wei Z G.; Rockey, J.H. 1990: Prostacyclin and histamine release in tears during a type i conjunctival reaction. IOVS Investigative Ophthalmology and Visual Science 31(4): 65
Schneider, M.R.; Tang, D.G.; Schirner, M.; Honn, K.V. 1994: Prostacyclin and its analogues: antimetastatic effects and mechanisms of action. Cancer Metastasis Reviews 13(3-4): 349-364
Stock, G.; Graf, H. 1992: Prostacyclin and its stable analogs in the treatment of critical ischaemia. Polish Journal of Pharmacology and Pharmacy 44(Suppl ): 69
Crutchley, D.J. 1992: Prostacyclin and monocytes Suppression of tissue factor procoagulant activity. Rubanyi, G M , Vane, J International Congress Series; Prostacyclin: New perspectives for basic research and novel therapeutic indications : 37-58
Gryglewski, R.J. 1994: Prostacyclin and nitric oxide. Acta Haematologica Polonica 25(2 Suppl 2: 75-81
Gryglewski, R.J.; Swies, J.; Grodzinska, L.; Kostka Trabka, E. 1998: Prostacyclin and nitric oxide as thrombolytics. European Journal of Clinical Investigation 28(Suppl 1): A44
Zhu, P.; Zaugg, C.; Hornstein, P.; Buser, P.T. 1994: Prostacyclin and nitric oxide contribute to the protective effects of bradykinin on the post-ischaemic damaged myocardium. European Heart Journal 15(ABSTR Suppl ): 97
Zhu, P.; Zaugg, C.; Hornstein, P.; Buser, P.T. 1994: Prostacyclin and nitric oxide contribute to the protective effects of bradykinin on the postischemic reperfused myocardium. European Journal of Clinical Investigation 24(Suppl 2): A45
Torti, M.; Lapetina, E.G. 1992: Prostacyclin and platelets A novel signal transduction mechanism. Rubanyi, G M , Vane, J International Congress Series; Prostacyclin: New perspectives for basic research and novel therapeutic indications : 25-35
Grossi, I.M.; Taylor, J.D.; Honn, K.V. 1989: Prostacyclin and prostacyclin analogs inhibit tumor cell adhesion to substrata through inhibition of membrane expression of the integrin receptor irgpiib iiia. Proceedings of the American Association for Cancer Research 30: 82
Kerstein, D.; Long, W.A.; Barst, R.J. 1992: Prostacyclin and prostaglandin e1 in pulmonary hypertension. American Review of Respiratory Disease 145(4 Part 2): A716
Minuz, P.; Barrow, S.E.; Cockcroft, J.R.; Ritter, J.M. 1989: Prostacyclin and thromboxane biosynthesis in essential hypertension. Journal of Hypertension 7(11): 921
Tanabe, T.; Ullrich, V. 1995: Prostacyclin and thromboxane synthases. Journal of Lipid Mediators and Cell Signalling 12(2-3): 243-255
Dusting, G.J.; MacDonald, P.S. 1990: Prostacyclin and vascular function: implications for hypertension and atherosclerosis. Pharmacology and Therapeutics 48(3): 323-344
Graf, H. 1992: Prostacyclin and vascular remodeling. Rubanyi, G M, Vane, J International Congress Series; Prostacyclin: New perspectives for basic research and novel therapeutic indications: 139-147
Nikolov, R. 1989: Prostacyclin as a cerebroprotective agent against brain hypoxia. Biomedica Biochimica Acta 48(2-3): S183-S187
Zellers, T.M.; Vanhoutte, P.M. 1989: Prostacyclin causes endothelium dependent relaxations in porcine pulmonary arteries. Pediatric Research 25(4 Part 2): 373A
Taylor, C.M.; Lote, C.J. 1992: Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis. Archives of Disease in Childhood 67(11): 1412-1413
Holtzman, R.B.; Adler, L.; Shamsuddin, M.; Hageman, J.R. 1989: Prostacyclin decreases lung neutrophil influx in oxygen exposed maturing rabbits. Pediatric Research 25(4 Part 2): 313A
Rovati, G.E.; Giovanazzi, S.; Negretti, A.; Nicosia, S. 1995: Prostacyclin effects on adenylate cyclase in platelets and vascular smooth muscle: interaction with an inhibitory receptor or partial agonism?. Advances in Prostaglandin Thromboxane and Leukotriene Research 23: 263-265
Tarnawski, A.; Stachura, J.; Sarfeh, I.J.; Sekhon, S.; Krause, W.J.; Gergely, H. 1991: Prostacyclin endothelial cell growth factor and antacid stimulate angiogenesis in injured gastric mucosa. Gastroenterology 100(5 Part 2): A174
Mcnamara, D.B.; Saroyan, R.M.; Bang, D.J.; Kerstein, M.D.; Vaccarella, M.Y.; Kadowitz, P.J. 1989: Prostacyclin formation by abdominal and thoracic aorta after balloon angioplasty. Circulation 80(4 Suppl 2): II227
Hofman W.F.; El Kashef H.; Ehrhart I.C. 1990: Prostacyclin formation with serotonin infusion increased blood flow or elevated venous pressure in the isolated dog lung. FASEB Journal 4(3): A275
Gabaldón, M.; Martínez-Sales, V.; Capdevila, C.; Zúñiga, A. 1993: Prostacyclin generation by rat aortas obtained by different procedures. Journal of Pharmacological and Toxicological Methods 30(3): 159-162
Montalescot, G.; Meurin, P.; Drobinski, G.; Maclouf, J.; Thomas, D. 1997: Prostacyclin has a positive inotropic effect in patients with severe heart failure. European Heart Journal 18(ABSTR Suppl ): 292
Gruene, S.; Schinharl, D.; Michl, M.; Reng, M.; Frick, E.; Schoelmerich, J. 1998: Prostacyclin has a protective effect against the rapid LPS induced decrease of the Indocyanine-green clearance rate. Hepatology 28(4 Part 2): 621A
Buongiorno, E.; Abatelillo, S.; Accoto, S.; D'agostino, F.; D'elia, F.; Lupo, N.; Navarra, A.; Petraurolo, F.; Virgilio, M. 1995: Prostacyclin in HD patients with peripheral arterial disease. Nephrology Dialysis Transplantation 10(6): 1003
Schorer, A. 1994: Prostacyclin in a murine model of lupus anticoagulant. Blood 84(10 Suppl 1): 698A
Roesen, P.; Tschoepe, D. 1992: Prostacyclin in diabetes Metabolism and therapeutic use. Rubanyi, G M , Vane, J International Congress Series; Prostacyclin: New perspectives for basic research and novel therapeutic indications : 201-230
Buongiorno, E.; Abatelillo, S.; Accoto, S.; Lupo, N.; Merico, G.; Schiavano, S.; Grandolfo, N. 1996: Prostacyclin in hemodialysis patients with peripheral arterial disease Follow up after 12-18 months of cyclic treatment. Nephrology Dialysis Transplantation 11(6): A178
Magnani, B.; Galiè, N. 1996: Prostacyclin in primary pulmonary hypertension. European Heart Journal 17(1): 18-24
Topilsky, M.; Heller, I. 1993: Prostacyclin in primary pulmonary hypertension: a bridge to heart-lung transplantation. Israel Journal of Medical Sciences 29(10): 656-657
Brudno, D.S.; Hofman, W.F.; Ehrhart, I.C. 1995: Prostacyclin in the regulation of vascular tone and permeability in the isolated dog lung. FASEB Journal 9(3): A111
Wesson, D.E. 1996: Prostacyclin increases HCO-3 secretion in the rat distal tubule. Journal of the American Society of Nephrology 7(9): 1264
Hoeper, M.M.; Voelkel, N.F.; Bates, T.O.; Tuder, R.M. 1995: Prostacyclin increases vascular endothelial growth factor in human monocytes and rat lung via a cyclic AMP-dependent mechanism. European Respiratory Journal 8(Suppl 19): 466S
Langleben, D.; Long, W.A.; Barst, R.J.; Tapson, V.F.; Groves, B.M.; Badesch, D.B.; Bourge, R.C.; Murali, S.; Ettinger, N.; Shalit, E.; Stewart, D.J. 1995: Prostacyclin infusion improves the balance between pulmonary clearance and production of endothelin-1 in patients with primary pulmonary hypertension. Circulation 92(8): I241
Schenk, P.; Ratheiser, K.; Apsner, R.; Madl, C.; Ziesche, R.; Lenz, K.; Burghuber, O.C.; Kneussl, M. 1995: Prostacyclin infusion, nitric oxide inhalation and oral nifedipine in a patient with primary pulmonary hypertension. Atemwegs- und Lungenkrankheiten 21(6): 304-307
Nasser, M.G.; Frangoul, H.; Shammas, N.W.; Nasser, C.F.; Habbal, M.Z. 1992: Prostacyclin inhibited taurine accumulation by the rat left ventricle. FASEB Journal 6(4): A1486
Lindemann, S.; Gierer, C.; Buerke, M.; Grosser, T.; Ibe, W.; Meyer, J.; Darius, H. 1998: Prostacyclin inhibits PMN-adhesion to stimulated human vascular endothelial cells due to an enhanced endothelial interleukin-8 release. European Heart Journal 19(ABST Suppl ): 380
Lindemann, S.; Gierer, C.; Grosser, T.; Buerke, M.; Darius, H. 1998: Prostacyclin inhibits endothelial PAF-release and reduces PMN-adhesion to human endothelial cells in an adhesion molecule independent manner. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4): R176
Pawlak, R.; Chabielska, E.; Golatowski, J.; Azzadin, A.; Buczko, W. 1997: Prostacyclin is involved in antithrombotic effect of captopril in venous thrombosis in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 356(4 Suppl 1: R42
Khoury, G.F.; Foster, S.; Raybould, D.; Nyerges, A.; Katz, R.; Busuttil, R.W. 1990: Prostacyclin levels during orthotopic liver transplantation. Transplantation Proceedings 22(4): 1525-1527
Komura, H.; Bukoski, R.D.; Karanja, N.; Shingu, T.; Mccarron, D.A. 1991: Prostacyclin lowers platelets intracellular free calcium in relation to stimulation of cyclic amp. Journal of the American Society of Nephrology 2(3): 743
Chen, X.; Liao D F. 1990: Prostacyclin mediated protection of captopril ramiprilat and iloprost against free radical injury on aortic endothelium. European Journal of Pharmacology 183(6): 2208-2209
Blankenship, J.W.; Stitely, S.; Scharffenberg, J.A.; Sandberg, L.B. 1992: Prostacyclin metabolism in rat aorta smooth muscle cells is altered by cholesterol and cholestane 3 beta 5 alpha 6 beta triol. FASEB Journal 6(4): A1390
Gross, G.J. 1993: Prostacyclin mimetics and steroids. Kloner, R A, Przyklenk, K Fundamental and Clinical Cardiology; Stunned myocardium: Properties, mechanisms, and clinical manifestations: 311-320
Mori, S.; Iwakura, H.; Takechi, S. 1989: Prostacyclin pgi 2 analogues us patent 4820836 april 11 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(2): 1251-1252
Mori, S.; Iwakura, H.; Takechi, S. 1989: Prostacyclin pgi 2 analogues us patent 4855449 august 8 1989. Official Gazette of the United States Patent and Trademark Office Patents 1105(2): 1126
Kirschenbaum, M.A.; Chopra, V.; Chaudhari, A. 1989: Prostacyclin pgi 2 is not a major prostanoid pg produced by cultured rabbit renal microvascular rmv endothelial cells ec. Kidney International 35(1): 293
Shaul, P.W.; Campbell, W.B.; Farrar, M.; Magness, R.R. 1991: Prostacyclin pgi 2 production in the pulmonary artery pa is developmentally regulated in the perinatal period. FASEB Journal 5(6): A1723
Nelson, S.K.; Mathias, M.M.; Allen, K.G.D. 1991: Prostacyclin pgi 2 synthesis in basal and thrombin challenged aortic rings is depressed in copper deficient and copper marginal rats. FASEB Journal 5(5): A1454
Diss, E.; Robinson, A.; Gabbe, S.; O'shaughnessy R.; Reiss, R.; Moore, J.; Fertel, R.; Kniss, D. 1992: Prostacyclin pgi2 and thromboxane tx a2 production in first trimester trophoblasts effects of arachidonic acid aa and aspirin asa. American Journal of Obstetrics and Gynecology 166(1 Part 2): 368
Janowiak, M.A.; Holyoak, G.R.; Martin, P.H.; Vagnoni, K.E. 1998: Prostacyclin production by lipopolysaccharide-treated arteries from luteal versus follicular phase ewes. Journal of Dairy Science 81(Suppl 1): 239
Huang, M.C.; Craig Schmidt, M.C. 1994: Prostacyclin production by lung of neonatal pigs fed formula supplemented with very long chain polyunsaturated fatty acids. FASEB Journal 8(4-5): A425
Mccarron, R.M. 1991: Prostacyclin production by murine cerebral vascular endothelial cells. FASEB Journal 5(6): A1780
Boswell, D.J.; Biggerstaff, J.P.; Wilbourn, B.R.; Thompson, R.P.H.; Punchard, N.A. 1992: Prostacyclin production in normal and immortalised umbilical endothelial cells. Clinical Science 82(3): 19P-20P
Christman, B.W.; Mcpherson, C.D.; Newman, J.H.; King, G.A.; Bernard, G.R.; Groves, B.M.; Loyd, J.E. 1992: Prostacyclin production is reduced in patients with pulmonary hypertension. American Review of Respiratory Disease 145(4 Part 2): A717
Vorbrueggen, H.; Skuballa, W.; Klar, U.; Schillinger, E.; Thierauch K H.; Mueller, B.; Stuerzebecher C S.; Krais, T. 1989: Prostacyclin receptor agonists. Abstracts of Papers American Chemical Society 197: MEDI 2
Darius, H.; Michael Hepp, J.; Meyer, J. 1993: Prostacyclin receptor desensitization on platelet by iloprost but not by the analog taprostene. European Heart Journal 14(ABSTR Suppl ): 180
Nasrallah, R.; Hebert, R.L. 1998: Prostacyclin receptor mRNA expression in rat kidney. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 414A
Maggi, R.; Pimpinelli, F.; Capra, V.; Rovati, G.E.; Martini, L.; Piva, F. 1997: Prostacyclin receptors are present on GT1-1 cells and are involved in the activation of luteinizing hormone-releasing hormone release. Journal of Endocrinology 152(Suppl ): P146
Pluta, R.; Salińska, E.; Lazarewicz, J.W. 1990: Prostacyclin reduces early ischemic changes in central nervous system. Acta Neurobiologiae Experimentalis 50(4-5): 295-302
Moriarty, K.J.; Higgs, N.B.; Tonge, A.; Lees, M.; Wardle, T.D.; Warhurst, G. 1990: Prostacyclin regulates secretion in mammalian colon via dual calcium and cyclic amp dependent mechanisms comparison with pge 2. Gastroenterology 98(5 Part 2): A549
Grose, J.H.; Caron, L.; Lebel, M. 1992: Prostacyclin regulatory mechanisms in cultured bovine aortic endothelial cells. Clinical and Investigative Medicine 15(4 Suppl): A68
Grose, J.H.; Caron, L.; Lebel, M.; Landry, J. 1991: Prostacyclin secretion and specific intracellular protein phosphorylation. Advances in Prostaglandin Thromboxane and Leukotriene Research 21a: 145-148
Lee, J.J.; Ishikawa, T.; Safeh, I.J.; Ishikawa, N.; Douglass, T.G.; Tarnawski, A. 1992: Prostacyclin stable analog protects gastric mucosa against ischemia reperfusion injury. Gastroenterology 102(4 Part 2): A220
Tanabe, T. 1998: Prostacyclin synthase derived from human. Official Gazette of the United States Patent and Trademark Office Patents 1214(5): 5301
Numaguchi, Y.; Naruse, K.; Harada, M.; Toki, Y.; Okumura, K.; Ito, T. 1998: Prostacyclin synthase gene delivery inhibits neointimal formation after balloon injury in rat carotid arteries. European Heart Journal 19(ABST Suppl ): 495
Harada, M.; Numaguchi, Y.; Toki, Y.; Okumura, K.; Ito, T. 1998: Prostacyclin synthase gene transfer and exogenous beraprost sodium, a prostacyclin analogue, protect against neointimal formation in balloon-injured rat carotid arteries. European Heart Journal 19(ABST Suppl ): 188
Numaguchi, Y.; Naruse, K.; Harada, M.; Osanai, H.; Toki, Y.; Okumura, K.; Ito, T. 1998: Prostacyclin synthase gene transfer inhibits neointimal formation after balloon injury with acceleration of re-endothelialization. Circulation 98(17): I670
Giordano, M.J.; Moore, S.A. 1990: Prostacyclin synthase inhibition by metyrapone in cerebromicrovessel endothelium cme. Circulation 82(4 Suppl 3): III179
Wright, H.M.; Malik, K.U. 1996: Prostacyclin synthesis elicited by endothelin-1 in rat aorta is mediated by a pertussis toxin-insensitive G protein via activation of phospholipase D but not PLC or PLA-2. FASEB Journal 10(3): A146
Xu, X.M.; Sanduja, S.K.; Ohashi, K.; Wang, L.H.; Wu, K.K. 1992: Prostacyclin synthesis in cultured endothelial cells is markedly enhanced by transfer of prostaglandin H synthase gene with a retroviral vector. Circulation 86(4 Suppl 1): I152
Brannon, T.; North, A.; Wells, L.; Shaul, P. 1993: Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase expression. Pediatric Research 33(4 Part 2): 62A
Beckmann, M.L.; Nies, A.S.; Gerber, J.G. 1989: Prostacyclin synthesis is increased during propranolol therapy for essential hypertension. Advances in Prostaglandin Thromboxane and Leukotriene Research 19: 203-206
Markov, K.M. 1989: Prostacyclin thromboxane balance and risk factors in coronary heart disease. Kardiologiya 29(9): 5-12
Eronen, M.; Pohjavuori, M.; Pesonen, E.; Adersson, S.; Raivio, K.O. 1993: Prostacyclin treatment of persistent pulmonary hypertension of the newborn. Pediatric Research 33(4 Part 2): 33A
Traverse, J.H.; Judd, D.L.; Pavek, T.J.; Crampton, M.J.; Bache, R.J. 1996: Prostacyclin, but not nitric oxide, mediates the vasodilator response to endothelin-1 in the coronary circulation. Journal of the American College of Cardiology 27(2 Suppl A): 322A
Jeremy, J.Y.; Southgate, K.M.; Knight, D.; Angelini, G.D.; Thompson, C.S.; Sullivan, M.; Morgans, R.J.; Mikhailidis, D.P. 1996: Prostacyclin, cyclic AMP and metalloproteinase activity in diabetic rabbit aortae. International Journal of Microcirculation Clinical and Experimental 16(4): 209
Honn, K.V.; Chen, Y.Q. 1992: Prostacyclin, hydroxy fatty acids and cancer metastasis. Rubanyi, G M, Vane, J International Congress Series; Prostacyclin: New perspectives for basic research and novel therapeutic indications: 181-200
Mehta, D.; Jeremy, J.Y.; Izzat, M.B.; Bryan, A.J.; Angelini, G.D. 1996: Prostacyclin, nitric oxide and cyclic nucleotide synthesis in stented and unstented porcine vein grafts. British Journal of Pharmacology 119(Proceedings Suppl ): 132P
Gryglewski, R.J.; Chłopicki, S.; Swies, J.; Niezabitowski, P. 1995: Prostacyclin, nitric oxide, and atherosclerosis. Annals of the new York Academy of Sciences 748: 194-206; Discussion: 206-207
Schenk, P.; Ratheiser, K.; Apsner, P.; Madl, C.; Lenz, K.; Burghuber, O.C.; Kneussl, M. 1996: Prostacyclin, nitrous oxide, and nifedipine in a patient with primary pulmonary hypertension. Wiener Klinische Wochenschrift 108(Suppl 1): 36-37
Kunisaki, M.; Ono, Y.; Sekiguchi, N.; Yamauchi, T.; Umeda, F.; Nawata, H. 1997: Prostacyclin-stimulating factor is regulated by protein kinase C activation induced by high glucose levels in diabetes mellitus. Diabetologia 40(Suppl 1): A434
Moreno, A.; De La Cruz, J.P.; Garcia Campos, J.; Sanchez De La Cuesta, F. 1995: Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes. Canadian Journal of Ophthalmology. Journal Canadien d'Ophtalmologie 30(3): 117-123
Sibasaki, M.; Sodeoka, M.; Iseki, K.; Shinoda, M.; Aoki, C.; Hayasi, Y.; Kanayama, T. 1989: Prostacyclins and pharmaceuticals containing the same us patent 4839388 june 13 1989. Official Gazette of the United States Patent and Trademark Office Patents 1103(2): 1263
Stuerzebecher, C S.; Witt, W.; Raduechel, B.; Skuballa, W.; Vorbrueggen, H. 1996: Prostacyclins, their analogs or prostaglandins and thromboxane antagonists for treatment of thrombotic and thromboembolic syndromes. Official Gazette of the United States Patent and Trademark Office Patents 1187(1): 416
Stjernschantz, J.W.; Resul, B. 1995: Prostaglanddin derivatives for the treatment of glaucoma or ocular hypertension. Official Gazette of the United States Patent and Trademark Office Patents 1175(1): 445
Ota, S.; Takahashi, M.; Terano, A.; Nishimura, S.; Okamoto, M.; Ogura, K.; Shimada, T.; Hamada, E.; Omata, M. 1994: Prostaglandin -independent cytoprotective action of sucralfate against noxious agents in rabbit gastric epithelial cells in primary culture. Gastroenterology 106(4 Suppl): A153
Gutarra,M.L.E.; Burlandy,F.M.; Meneses,M.D.R.de; Cortez,L.P.; Rebello,M.A. 2008: Prostaglandin A1 inhibits the replication of Sindbis virus in monkey kidney and mosquito cells. Revista De Ciencias Medicas E Biologicas: 2, 169-174
Melegos, D.N.; Freedman, M.S.; Diamandis, E.P. 1997: Prostaglandin D synthase in cerebrospinal fluid and serum from patients with various neuropathologies. Clinical Chemistry 43(6 Part 2): S185
Yamashima, T.; Sakuda, K.; Yamashita, J.; Oda, H.; Beuckmann, C.T.; Urade, Y.; Hayaishi, O. 1997: Prostaglandin D synthase in human meninges. Neuroscience Research Suppl 1997(21): S77
Marcheselli, V.L.; Gordon, W.C.; Cinar, N.H.; Beuckmann, C.T.; Urade, Y.; Hayaishi, O.; Bazan, N.G. 1996: Prostaglandin D synthase is rapidly translocated from the retinal pigment epithelium into the interphoto-receptor matrix, vitreous and aqueous humor. FASEB Journal 10(6): A1258
Hayaishi, O.; Matsumura, H.; Urade, Y. 1993: Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep. Journal of Lipid Mediators 6(1-3): 429-431
Rodriguez, C.M.; Gerena, R.L.; Day, J.R.; Killian, G.J. 1998: Prostaglandin D synthase mRNA and protein expression in the bull tests and epididymis. Biology of Reproduction 58(Suppl 1): 183
Thierauch, K.H.; Schillinger, E.; Buchmann, B.; Rehwinkel, H.; Skuballa, W. 1992: Prostaglandin D-2 and its analogs. Drugs of the Future 17(9): 809-817
Torres, D.; Paget, C.; Fontaine, J.; Mallevaey, T.; Matsuoka, T.; Maruyama, T.; Narumiya, S.; Capron, M.; Gosset, P.; Faveeuw, C.; Trottein, Fçois. 2008: Prostaglandin D2 inhibits the production of IFN-gamma by invariant NK T cells: consequences in the control of B16 melanoma. Journal of Immunology 180(2): 783-792
Warren, J.B.; Loi, R.K.; Wilson, A.J. 1994: Prostaglandin D-2 is an intermediate in agonist-stimulated nitric oxide release in the rabbit skin microcirculation in vivo. British Journal of Pharmacology 111(Proceedings Suppl JAN ): 98P
Durand, M.; Gallant, M.A.; de Brum-Fernandes, A.J. 2008: Prostaglandin D2 receptors control osteoclastogenesis and the activity of human osteoclasts. Journal of Bone and Mineral Research: the Official Journal of the American Society for Bone and Mineral Research 23(7): 1097-1105
Pan, M.; Wasa, M.; Souba, W.W. 1995: Prostaglandin D-2 regulates the glutamine/glutamate shuttle in human vascular endothelium. Surgical Forum 46: 18-21
Sorrentino, C.; Mo, M.Y.; Silvestrini, B.; Cheng, C.Y. 1997: Prostaglandin D-2 synthetase Its cellular distribution and hormonal regulation in the male reproductive tract. Biology of Reproduction 56(Suppl 1): 111
Nagoshi, H.; Uehara, Y.; Goto, A.; Omata, M. 1996: Prostaglandin D2 inhibits nitric oxide synthase expression in smooth muscle cells. Hypertension 28(3): 549
Civati, G.; Brando, B.; Busnach, G.; Broggi, M.L.; Guastoni, C.; Ballerini, L.; Teatini, U.; Montoli, A.; Minetti, L. 1992: Prostaglandin E analogue can improve kidney graft functional recovery. Journal of the American Society of Nephrology 3(3): 854
Sugimoto, Y.kihiko; Negishi, Manabu; Ichikawa, Atsushi; Shigemoto, Ryuichi; Mizuno, Noboru; Namba, Tsunehisa; Narumiya, Shuh 1993: Prostaglandin E receptor EP-3 mRNA expression in mouse central nervous system. Japanese Journal of Pharmacology 61(Suppl 1): 85P
Takeuchi, K.; Yagi, K.; Tashima, K.; Furukawa, O.; Ukawa, H. 1998: Prostaglandin E receptor subtypes involved in gastric cytoprotection against ethanol in rats. Gastroenterology 114(4 Part 2): A305
Negishi, M.; Sugimoto, Y.; Ichikawa, A. 1995: Prostaglandin E receptors. Journal of Lipid Mediators and Cell Signalling 12(2-3): 379-391
Ichikawa, A.; Narumiya, S. 1996: Prostaglandin E receptors, their DNA and production. Official Gazette of the United States Patent and Trademark Office Patents 1192(3): 2027
Evans, D.H.; Gunderson, M.P. 1997: Prostaglandin E, not nitric oxide, is the endothelium-derived relaxing factor in the shark ventral aorta. FASEB Journal 11(3): A93
Hirata, K.; Mabashi, K.; Horie, T. 2005: Prostaglandin E, transport into rat intestinal cryptic cell line IEC-6. Research Communications in Molecular Pathology and Pharmacology 117: 115-124
Sato, F.; Amano, T.; Kameo, K.; Tanami, T.; Mutoh, M.; Ono, N.; Goto, J. 1995: Prostaglandin E-1 analogues. Official Gazette of the United States Patent and Trademark Office Patents 1178(2): 1029
Allen, C.; Taub, M. 1993: Prostaglandin E-1 and 8-bromo cyclic AMP regulate the level of the mRNA for the sodium, potassium-ATPase in Madin Darby canine kidney cells in serum free medium. FASEB Journal 7(7): A1146
Iberer, F.; Muller, H.; Wasler, A.; Tscheliessnigg, K.H.; Auer, T.; Petutschnigg, B. 1994: Prostaglandin E-1 and heart transplantation. Koerner, M M, Posival, H, Koerfer, R International Congress Series; Thoracic organ transplantation: Routine as a challenge 59-66
Marchesini, G.; Fabbri, A.; Brizi, M.; Bianchi, G.P.; Zoli, M. 1997: Prostaglandin E-1 and hepatic amino acid-N metabolism in cirrhosis. Journal of Hepatology 26(Suppl 1): 123
Mariani, G.; Ambalavanan, N.; Bulger, A.; Philips, J.B.IIi 1997: Prostaglandin E-1 and peptide growth factors stimulate neonatal pulmonary artery smooth muscle cell proliferation in a synergistic manner. Journal of Investigative Medicine 45(1): 66A
Hide, E.; Ney, P.; Thiemermann, C.; Vane, J.R. 1994: Prostaglandin E-1 and prostaglandin E-0 reduce infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. British Journal of Pharmacology 112(Proceedings Suppl MAY): 383P
Zoli, M.; Fabbri, A.; Magalotti, D.; Bianchi, G.P.; Marchesini, G. 1997: Prostaglandin E-1 and systemic and splanchnic hemodynamics in cirrhosis. Journal of Hepatology 26(Suppl 1): 267
Sison, A.Jr; Godschalk, M.; Mulligan, T. 1997: Prostaglandin E-1 as treatment for erectile dysfunction in hypertensive elderly men. Journal of the American Geriatrics Society 45(9): S65
Kong, L.B.; Hoffman, A.L.; Pan, S.H.; Cordero, R.; Sher, L.S.; Podesta, L.; Lopez, R.; Vierling, J.; Villamil, F.; Rojter, S.; Woolf, G.; Demetriou, A.A.; Makowka, L. 1995: Prostaglandin E-1 for severe, early hepatic dysfunction following orthotopic liver transplantation. Hepatology 22(4 Part 2): 439A
Togo, S.; Chen, H.; Takahashi, T.; Kubota, T.; Matsuo, K.; Morioka, D.; Watanabe, K.; Yamamoto, H.; Nagashima, Y.; Shimada, H. 2008: Prostaglandin E1 improves survival rate after 95% hepatectomy in rats. Journal of Surgical Research 146(1): 66-72
Agnoletti, G.; Cavazza, A.; Milani, M.; Verri, B. 1994: Prostaglandin E1 in a case of cardiogenic shock in a very low-birth-weight infant. Acta Paediatrica 83(8): 877-879
Smith, D.G.; Remmert, C.S.; Henley, K.S. 1994: Prostaglandin E-1 in liver transplantation A pharmacoeconomic analysis. Hepatology 20(4 Part 2): 124A
Davidson, S.M.K.; Minchey, S.R.; Janoff, A.S. 1997: Prostaglandin E-1 induces a ripple phase in dipalmitoylphosphatidylcholine multilamellar vesicles. Biophysical Journal 72(2 Part 2): A73
Kikura, M.; Kazama, T.; Ikeda, K. 1997: Prostaglandin E-1 inhibits and reverses platelet aggregation in vitro, and mildly inhibits platelet function in vivo in human whole blood. Anesthesiology 87(3 Suppl): A78
Mccarthy, G.M.; Cheung, H.S. 1993: Prostaglandin E-1 inhibits basic calcium phosphate crystal-induced mitogenesis and collagenase induction via cyclic-3,5-monophosphate. Arthritis and Rheumatism 36(9 Suppl): S161
Lakin, M.M.; Chen, R.N.; Llorens, S.A.; Klein, E.A.; Montague, D.K.rl 1996: Prostaglandin E-1 injection therapy for post-prostatectomy impotence An outcome analysis. Journal of Urology 155(5 Suppl): 470A
Hide, E.; Piper, J.; Ney, P.; Thiemermann, C.; Vane, J.R. 1995: Prostaglandin E-1 or prostaglandin E-O attenuates the reperfusion injury in the ischaemic rabbit heart in vivo. British Journal of Pharmacology 115(Proceedings Suppl JULY): 77P
Miwa, T.; Shugyo, H.; Endou, M. 1995: Prostaglandin E-1 potentiates phasic contraction in isolated rat portal vein by cyclopiazonic acid-sensitive mechanism. Japanese Journal of Pharmacology 67(Suppl 1): 179P
Hide, E.; Dhein, S.; Piper, J.; Gottwald, E.; Ney, P.; Thiemermann, C. 1996: Prostaglandin E-1 protects against reperfusion injury and attenuates endothelial P-selectin expression in a rabbit model of myocardial ischaemia and reperfusion. British Journal of Pharmacology 118(Proceedings Suppl JULY): 90P
Van Ness, K.; Podkameni, D.; Noerdlinger, M.; Schwartz, M.; Miller, C. 1993: Prostaglandin E-1 protects rat livers against reperfusion injury. Hepatology 18(4 Part 2): 345A
Sinzinger, H.; Fitscha, P.; Kritz, H.; Schmid, P.; Peskar, B.A. 1996: Prostaglandin E-1 therapy for peripheral vascular disease induces a long-lasting benefit on microalbuminuria. Circulation 94(8): I96
Tancharoen, S.; Jones, R.M.; Angus, P.W.; Michell, I.D.; McNicol, L.; Hardy, K.J. 1992: Prostaglandin E1 therapy in orthotopic liver transplantation recipients: indications and outcome. Transplantation Proceedings 24(5): 2248-2249
Naito, Y.; Sone, T.; Kito, K.; Yamazaki, K. 1997: Prostaglandin E-1 upregulates production of TH2-type cytokines in patients undergoing upper abdominal surgery. Anesthesiology 87(3 Suppl): A245
Pacher, R.; Stanek, B.; Hulsmann, M.; Siegel, A.; Berger, R.; Frey, B.; Wutte, M.; Daneshvar, H.; Zuckermann, A.; Wieselthaler, G.; Laufer, G.; Wolner, E. 1995: Prostaglandin E-1-bridging to heart transplantation. European Heart Journal 16(ABSTR Suppl ): 99
Blatteis, C.M.; Sehic, E. 1997: Prostaglandin E-2 A putative fever mediator. News in Physiological Sciences 12(FEB ): 1-9
Suhovskaya, O.; Borisenko, L.; Aleksandrova, N. 1996: Prostaglandin E-2 and F-2alpha in patients with bronchoobstructive and acute bronchitis. European Respiratory Journal Suppl 9(23): 463S
Good, D.W.; George, T. 1992: Prostaglandin E-2 and G protein regulation of bicarbonate absorption in rat medullary thick ascending limb. Journal of the American Society of Nephrology 3(3): 777
Baylink, T.; Mohan, S.; Linkhart, T.; Baylink, D. 1994: Prostaglandin E-2 and PGF-2alpha produce biphasic mitogenic dose responses in human bone cells in vitro. Clinical Research 42(1): 49A
Synnerstad, I.; Holm, L. 1996: Prostaglandin E-2 and irritating agents increase the gland luminal pressure in the rat gastric mucosa in vivo. Gastroenterology 110(4 Suppl): A267
Tsuchiya, H.; Oka, T.; Nakamura, K.; Ichikawa, A.; Saper, C.B.; Sugimoto, Y. 2008: Prostaglandin E2 attenuates preoptic expression of GABAA receptors via EP3 receptors. Journal of Biological Chemistry 283(16): 11064-11071
Horner, A.A.; Beck, L.G.; Spiegelberg, H. 1996: Prostaglandin E-2 causes inhibition of CD40 ligand expression on activated human T-cells which is reversible with IL-2 or IL-4. Journal of Allergy and Clinical Immunology 97(1 Part 3): 360
Arai, M.; Thurman, R.G.; Lemasters, J.J. 1997: Prostaglandin E-2 derived from Kupffer cells protects sinusoidal endothelial cells against storage/reperfusion injury. Hepatology 26(4 Part 2): 349A
Lo, C.J.; Fu, M.; Lo, F.R.; Cryer, G. 1997: Prostaglandin E-2 downregulation of alveolar macrophages occurs at the posttranscriptional level. Surgical Forum 48: 56-58
Lopshire, J.C.; Nicol, G.D. 1996: Prostaglandin E-2 enhances the sensitivity of rat sensory neurons to capsaicin. Society for Neuroscience Abstracts 22(1-3): 1813
Nicol, G.D.; Cui, M. 1992: Prostaglandin E-2 enhances the sensitivity to bradykinin in rat sensory neurons grown in culture. Society for Neuroscience Abstracts 18(1-2): 690
Sakai, H.; Zhang, D.; Nakata, K.; Shirasawa, E.; Beuerman, R.W. 1996: Prostaglandin E-2 enhances the sensory nerve response to mechanical, chemical and thermal stimulation of rabbit cornea. IOVS Investigative Ophthalmology and Visual Science 37(3): S548
Yamashita, H.; Setiadji, S.; Shibuya, I.; Kabashima, N.; Tanaka, K.; Harayama, N.; Ueta, Y. 1997: Prostaglandin E-2 excites rat supraoptic neurons by directly activating postsynaptic cation channels. Society for Neuroscience Abstracts 23(1-2): 418
Osaka, T. 2008: Prostaglandin E(2) fever mediated by inhibition of the GABAergic transmission in the region immediately adjacent to the organum vasculosum of the lamina terminalis. Pflugers Archiv: European Journal of Physiology 456(5): 837-846
Anonymous 1993: Prostaglandin E-2 gel for cervical ripening. International Journal of Gynecology and Obstetrics 42(2): 212-214
Hu, S.S.u-Jung; Bradshaw, H.B.; Chen, J.S.C.; Tan, B.; Walker, J.M.chael 2008: Prostaglandin E-2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NF kappa B activity. British Journal of Pharmacology 153(7): 1538-1549
Sugimoto, N.; Simons, C.T.; Szekely, M.; Romanovsky, A.A. 1997: Prostaglandin E-2 hyperthermia in vagotomized rats. FASEB Journal 11(3): A527
Tomas Barberan, S.; Fagerholm, P.; Torngren, L.; Lundberg, K.; Rolfsen, W. 1995: Prostaglandin E-2 increase in the aqueous humour after excimer laser photorefractive keratectomy in the rabbit cornea. IOVS Investigative Ophthalmology and Visual Science 36(4): S712
Hoeper, M.M.; Voelkel, N.F.; Dempsey, E.C.; Tuder, R.M. 1995: Prostaglandin E-2 increases vascular endothelial growth factor in monocytes and vascular smooth muscle cells. Circulation 92(8): I374
Ritchlin, C.; Haas Smith, S.; Smith, T.J.; Cappuccio, J.; Osterland, C.K.; Young, D. 1995: Prostaglandin E-2 induced morphological changes in psoriatic synovial fibroblastoid cells A unique phenotypic response. Journal of Investigative Medicine 43(Suppl 2): 336A
Zahner, G.; Disser, M.; Wolf, G.; Thaiss, F.; Schoeppe, W.; Stahl, R.A.K. 1993: Prostaglandin E-2 induced reduction of procollagen I and III mRNA in rat mesangial cells is independent of new protein synthesis and RNA degradation. Journal of the American Society of Nephrology 4(3): 459
Srock, S.; Beil, W.; Bleck, J.; Manns, M.P.; Wagner, S. 1997: Prostaglandin E-2 induces apoptosis and inhibits cell growth in human gastric cancer cells. Gastroenterology 112(4 Suppl): A662
Cheng, T.; Wen, R.; Cao, W.; Steinberg, R.H. 1996: Prostaglandin E-2 induces bFGF expression in cultured rat Muller cells. Society for Neuroscience Abstracts 22(1-3): 1971
Dekkers, J.A.J.M.; Kroese, A.B.A.; Akkermans, L.M.A. 1995: Prostaglandin E-2 induces excitation of myenteric neurons in the guinea pig ileum. Society for Neuroscience Abstracts 21(1-3): 1502
Goldring, M.B.; Suen, L.F.; Karsenty, G. 1994: Prostaglandin E-2 inhibits alpha-1 collagen gene transcription in fibroblasts through proximal promoter elements. Arthritis and Rheumatism 37(9 Suppl): S285
Ohia, S.; Al Zadjali, K.; Imler, M. 1993: Prostaglandin E-2 inhibits dopamine release from the rabbit retina. FASEB Journal 7(3-4): A263
Gurlo, T.; Huang, W.W.; Von Grafenstein, H. 1995: Prostaglandin E-2 inhibits interleukin-2 dependent proliferation of T-cells. Pharmaceutical Research (New York) 12(9 Suppl): S88
Torday, J.S.; Qin, J.T.; Sun, H. 1996: Prostaglandin E-2 integrates the hormonal- and stretch-stimulated production of surfactant. Pediatric Research 39(4 Part 2): 353A
Amin, A.R.; Marshall, P.J.; Attur, M.; Vyas, P.; Rediske, J.; Abramson, S.B. 1995: Prostaglandin E-2 is an inflammatory component in osteoarthritis-affected cartilage The yin-yang regulation of nitric oxide synthase and cyclooxygenase-2. Arthritis and Rheumatism 38(9 Suppl): S163
Zhou, H.; Gao, Y.; Ibe, B.O.; Raj, J.U.ha 1994: Prostaglandin E-2 is the most potent dilator PG in the developing pulmonary circulation. FASEB Journal 8(4-5): A413
Nishizaki, Y.; Guth, P.H.; Kaunitz, J.D. 1993: Prostaglandin E-2 maintains gastric surface cell pH homeostasis during acid exposure. Gastroenterology 104(4 Suppl): A159
Smith, G.S.; Vanwinkle, W.B.; Snuggs, M.B.; Bick, R.J.; Buja, L.M.; Miller, T.A. 1995: Prostaglandin E-2 mitigates microtubule damage in cultured rat enterocytes. Gastroenterology 108(4 Suppl): A325
England, S.; Bevan, S.; Docherty, R.J. 1996: Prostaglandin E-2 modifies tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurones in culture. Journal of Physiology (Cambridge) 491P: 145P
Ren, J.; Karpinski, E.; Benishin, C.G. 1992: Prostaglandin E-2 modulates I-K in subcultured rat tail artery vascular smooth muscle cells. Society for Neuroscience Abstracts 18(1-2): 796
Ren, J.; Karpinski, E.; Benishin, C.G. 1995: Prostaglandin E-2 modulates I-kappa in rat tail artery vascular smooth muscle cells. Blood Pressure 1995(Suppl 2): 123
Mccaffrey, T.V.; Yang, B.; Schlosser, R.J. 1995: Prostaglandin E-2 modulates ciliary beat frequency in human upper airway mucosa by production of endogenous nitric oxide. FASEB Journal 9(3): A146
Enss, M.L.; Heim, H.K.; Schmidt Wittig, U.; Sewing, K.F. 1994: Prostaglandin E-2 modulates glycosylation of mucins released from pig gastric mucous cells. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R64
Pugliese, G.; Pricci, F.; Romeo, G.; Romano, G.; Locuratolo, N.; Pugliese, F.; Mene, P.; Galli, G.; Casini, A.; Rotella, C.M.; Andreani, D.; Di Mario, U. 1995: Prostaglandin E-2 modulates high glucose-enhanced extracellular matrix production in rat mesangial cells. Diabetologia 38(Suppl 1): A207
Pugliese, Giuseppe; Pricci, Flavia; Di Mario, Umberto; Mene, Paolo; Pugliese, Francesco 1993: Prostaglandin E-2 modulates high glucose-stimulated matrix protein accumulation by cultured rat mesangial cells. Journal of the American Society of Nephrology 4(3): 801
Kolenko, V.; Bukowski, R.; Finke, J. 1996: Prostaglandin E-2 modulates the expression of JAK3 in naive and activated T lymphocytes. FASEB Journal 10(6): A1453
García Gil de Muñoz, F.L.; Martínez-Barnetche, J.; Lanz-Mendoza, H.; Rodríguez, M.H.; Hernández-Hernández, F.C. 2008: Prostaglandin E2 modulates the expression of antimicrobial peptides in the fat body and midgut of Anopheles albimanus. Archives of Insect Biochemistry and Physiology 68(1): 14-25
Kapraali, M.; Theodorsson, E.; Johansson, O.; Uribe, A. 1996: Prostaglandin E-2 modulates the gastrointestinal endocrine cell system. Gastroenterology 110(4 Suppl): A1087
Choudhury, A.R.; Lavigne, J.A.; Furuta, G.T.; Galli, S.J.; Wershil, B.K. 1993: Prostaglandin E-2 or pentoxifylline diminish tumor necrosis factor alpha production by mouse mast cells stimulated via the Fc-epsilon-RI. FASEB Journal 7(3-4): A41
Nishioka, F.Y. 1993: Prostaglandin E2 preparations for preinduction cervical ripening. Pharmacy considerations. Journal of Reproductive Medicine 38(1 Suppl): 83-88
Sekiyama, N.; Kobayashi, S. 1993: Prostaglandin E-2 presynaptically facilitates excitatory synaptic transmission in nucleus of solitary tract. Japanese Journal of Physiology 43(Suppl 2): S192
Smith, G.S.; Hendrix, M.J.C.; Mercer, D.W.; Miller, T.A. 1996: Prostaglandin E-2 pretreatment attenuates 45calcium accumulation and microtubule disruption in cultured rat intestinal cells exposed to ethanol. Gastroenterology 110(4 Suppl): A260
Smith, G.S.; Bick, R.J.; Snuggs, M.B.; Vanwinkle, W.B.; Buja, L.M.; Miller, T.A. 1995: Prostaglandin E-2 pretreatment attenuates calcium uptake in a model of ethanol-induced injury to intestinal cells in culture. FASEB Journal 9(3): A554
Tyler, T.L.; Lint, T.F. 1993: Prostaglandin E-2 pretreatment protects L929 cells from complement-mediated lysis but not antibody-dependent cellular cytotoxicity. Journal of Immunology 150(8 Part 2): 225A
Skelly, M.M.; O'donoghue, D.P.; Baird, A.W. 1997: Prostaglandin E-2 primes human colonic mucosa for the prosecretory action of immunocyte activators fMLP and anti-IgE. Gastroenterology 112(4 Suppl): A1094
Matsumoto, S.S.; Sabatine, S.C.; Anger, C.B. 1994: Prostaglandin E-2 production by cultured corneal epithelial cells as an in vitro measure of ocular toxicity. In Vitro Toxicology 7(2): 163
W.W.ng, C.Y.; Wang, S.L.; Slomiany, A.; Slomiany, B.L. 1993: Prostaglandin E-2 receptor in hamster buccal mucosa Effect of nicotine and benzo pyrene. FASEB Journal 7(3-4): A144
Loh, C.C.; Rotondo, D.; Dutta-Roy, A.K. 1993: Prostaglandin E2 receptors of a human monocytic cell line, U937 cells. Biochemical Society Transactions 21(1): 52s
Zhang, L.; Karpinski, E.; Benishin, C. 1994: Prostaglandin E-2 regulates voltage-gated potassium channels in neurohypophyseal nerve terminals. Society for Neuroscience Abstracts 20(1-2): 1520
Good, D.W.; George, T.; Caflisch, C.R. 1993: Prostaglandin E-2 regulation of ion transport is absent in medullary thick ascending limbs from spontaneously hypertensive rats. Journal of the American Society of Nephrology 4(3): 512
Roper, R.L.; Phipps, R.P. 1994: Prostaglandin E2 regulation of the immune response. Advances in Prostaglandin Thromboxane and Leukotriene Research 22: 101-111
Li, M.; Jee, W.S.; Ke, H.Z.; Liang, X.G.; Lin, B.Y.; Ma, Y.F.; Setterberg, R.B.; Jee, W.S. 1993: Prostaglandin E2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats. Bone 14(3): 283-288
Robertson, D.; Frazier, L.W. 1993: Prostaglandin E-2 stimulates intracellular free calcium in isolated cells of rat submandibular salivary gland. Journal of Dental Research 72(Special Issue): 239
Lee, R.K.; Knapp, S.; Zarach, J.; Wurtman, R.J. 1997: Prostaglandin E-2 stimulates overexpression of amyloid precursor protein in astrocyte cultures Inhibition by immunosuppressants. Society for Neuroscience Abstracts 23(1-2): 28
Lee, R.K.; Knapp, S.; Zarach, J.; Wurtman, R.J. 1997: Prostaglandin E-2 stimulates overexpression of amyloid precursor protein in cultured astrocytes Inhibition by cyclosporin A. Journal of Neurochemistry 69(Suppl): S103
Veldman, C.M.; Schlapfer, I.; Schmid, C. 1995: Prostaglandin E-2 stimulates sodium-dependent phosphate but not alanine transport in rat osteoblastic cells. Calcified Tissue International 56(5): 492
Enss, M.L.; Wagner, S.; Beil, W.; Heim, H.K.; Hedrich, H.J. 1997: Prostaglandin E-2 stimulates the secretion and alters the composition of mucins released by human gastric mucous cells. Gastroenterology 112(4 Suppl): A113
Zeng, L.; An, S.; Goetzl, E.J. 1996: Prostaglandin E-2 stimulation of secretion of matrix metalloproteinase-9 from HSB2 human T cells mediated by the EP-3-subtype of PGE-2 receptors. FASEB Journal 10(6): A1130
Evans, A.R.; Vasko, M.R.; Nicol, G.D. 1995: Prostaglandin E-2 suppresses a potassium current in rat sensory neurons. Society for Neuroscience Abstracts 21(1-3): 900
Machwate, M.; Rodan, S.B.; Rodan, G.A.; Harada, S. 1996: Prostaglandin E-2 suppresses apoptosis via a cAMP-dependent pathway in two rat periosteal cell lines. Molecular Biology of the Cell 7(Suppl ): 583A
Scutt, A. 1994: Prostaglandin E-2, calcitriol and parathyroid hormone can promote or inhibit osteogenesis by primary cultures of rat bone marrow stromal cells. Bone and Mineral 25(1): S22-S23
Nishizaki, Y.; Guth, P.H.; Kaunitz, J.D. 1993: Prostaglandin E-2, isoproterenol, and pentagastrin increase gastric mucosal blood flow during acid exposure in the absence of barrier disruption. Gastroenterology 104(4 Suppl): A269
Hanke, C.; Csukas, S.; Rewolinski, D.; Campbell, W.B. 1995: Prostaglandin E-2-induced aldosterone release from bovine zona glomerulosa cells is mediated by an EP-2 receptor. FASEB Journal 9(3): A112
Chae, B.S.; Shin, T.Y.; Kim, D.K.; Eun, J.S.; Leem, J.Y.; Yang, J.H. 2008: Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice. Archives of Pharmacal Research 31(4): 503-510
Nicola, C.; Lala, P.K.; Chakraborty, C. 2008: Prostaglandin E2-mediated migration of human trophoblast requires RAC1 and CDC42. Biology of Reproduction 78(6): 976-982
Neu, B.; Seidler, U.; Classen, M. 1993: Prostaglandin E-2-receptors in human gastric mucosa. Gastroenterology 104(4 Suppl): A158
Ji, H.; Dailey, T.L.; Long, V.; Chien, E.K. 2008: Prostaglandin E2-regulated cervical ripening: analysis of proteoglycan expression in the rat cervix. American Journal of Obstetrics and Gynecology 198(5): 536.E1-7
Guo, N.L.; Lu, D.P.; Zheng, H.; Lu, X.J.; Shi, Q.; Wu, T.; Fan, Y.M.; Zhang, J.; Huang, X.J.; Zhang, Y.C.; Jiang, B. 1993: Prostaglandin E1 against hemorrhagic cystitis and hepatic veno-occlusive disease after allogeneic bone marrow transplantation. Blood 82(10 Suppl 1): 409A
Neumann, I.; Rogatti, W.; Virgolini, I.; Firbas, W.; Sinzinger, H. 1996: Prostaglandin E1 and 13,14-dihydro PGE1 are diminishing radiation-induced arterial damage. Sinzinger, H F, Schroer, K Agents and Actions Supplements; Prostaglandins in the cardiovascular system 58-65
Mariani, G.; Ambalavanan, N.; Bulger, A.; Philips, J.B.IIi 1997: Prostaglandin E1 and peptide growth factors simulate neonatal pulmonary artery smooth muscle cell proliferation in a synergistic manner. Pediatric Research 41(4 Part 2): 260A
Orellana, S.A.; Winkler, D.J.; Avner, E.D. 1996: Prostaglandin E1 and serum modulate Madin Darby canine kidney cell responses to hepatocyte growth factor. Molecular Biology of the Cell 7(Suppl ): 114A
Canning, J.R.; Marchese, K. 1995: Prostaglandin E1 as a topical agent for treatment of erectile dysfunction. Journal of Urology 153(4 Suppl): 474A
Suzuki, H.; Suematsu, M.; Ishii, H.; Kato, S.; Mori, M.; Horie, Y.; Miura, S.; Nishino, T.; Tsuchiya, M. 1993: Prostaglandin E1 attenuates early reductive stress preceding zone-specific oxidative injury in hypoperfused rat liver. Gastroenterology 104(4 Suppl): A1002
Suzuki, H.; Shinoda, Y.; Mori, M.; Yokoyama, H.; Ishimura, Y.; Suematsu, M.; Watanabe, K.; Ishii, H. 1996: Prostaglandin E1 attenuates the expression of vascular endothelial growth factor in human hepatoblastoma cell lines. Hepatology 24(4 Part 2): 466A
Froelich, J.C.; Bippi, H. 1995: Prostaglandin E1 derivatives for transdermal administration and methods of treatment therewith. Official Gazette of the United States Patent and Trademark Office Patents 1180(1): 364
Shiraishi, Y.; Koyama, S.; Yokoyama, J.'ichiro; Igarashi, H.; Kimura, T. 1998: Prostaglandin E1 improves the long-term outcome of the hepatic and renal functions after radical surgery for esophageal cancer. Anesthesiology 89(3A): A193
Marino, P.; Barbieri, E.; Perini, P.; Molinari, G.; Prioli, A.; Zardini, P. 1993: Prostaglandin E1 improves the restrictive filling pattern of severe dilated cardiomyopathy by lowering pulmonary resistances. Circulation 88(4 Part 2): I256
Pacher, R.; Stanek, B. 1996: Prostaglandin E1 in heart failure: the Vienna experience. Wiener Klinische Wochenschrift 108(16): 491-495
Wetzel, T.; Berger, F.; Hafner, D.; Borchard, U. 1998: Prostaglandin E1 increases action potential duration in hypoxic atrial myocardium. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4): R76
Natori, S.; Fujii, Y.; Kurosawa, H.; Nakano, A.; Shimada, H. 1996: Prostaglandin E1 intraportal infusion protects against ischemia-reperfusion injury of the rat liver. Gastroenterology 110(4 Suppl): A1275
Vasan, S.S.; Lim, P.H.C. 1997: Prostaglandin E1 or vacuum tumescence device Retrospective study of acceptance and satisfaction in Singapore. International Journal of Andrology 20(Suppl 1): 104
Natori, S.; Fujii, Y.; Kurosawa, H.; Nakano, A.; Shimada, H. 1997: Prostaglandin E1 protects against hepatic reperfusion injury by selective suppression of ICAM-1 expression. Gastroenterology 112(4 Suppl): A1344
Rau, H.P.; Thaiss, F.; Wolf, G.; Zahner, G.; Nelson, P.; Krensky, A.; Schoeppe, W.; Stahl, R.A. 1993: Prostaglandin E1 reduces the expression of the chemokine rantes in glomeruli of rats with immune mediated mesangial cell injury. Journal of the American Society of Nephrology 4(3): 629
Stahl, R.A.K.; Schneider, A.; Thaiss, F.; Rau, P.; Zahner, G.; Helmchen, U. 1994: Prostaglandin E1 reduces the proliferation of glomerular cells and expression of collagen types III and IV in anti-thymocyte-antibody induced glomerulonephritis. Journal of the American Society of Nephrology 5(3): 685
Hollenbeck, M.; Dinter, K.; Torsello, G.; Sandmann, W.; Grabensee, B. 1998: Prostaglandin E1 reduces the risk of delayed graft function after kidney transplantation. Kidney and Blood Pressure Research 21(2-4): 158-159
Offner, G.D.; Nunes, D.P.; Moore, E.W.; Afdhal, N.H. 1995: Prostaglandin E1 stimulates mucin secretion and increases MUC3 mRNA levels in cultured human gallbladder epithelial cells. Hepatology 22(4 Part 2): 110A
Wegner, H.E.H.; Knispel, H.H.; Miller, K. 1994: Prostaglandin E1 versus SIN-1 versus SIN-1 and urapidil in erectile dysfunction A double-blind cross over trial. Journal of Urology 151(5 Suppl): 455A
Arakawa, T.; Watanabe, T.; Fukuda, T.; Higuchi, K.; Tarnawski, A.; Kobayashi, K. 1994: Prostaglandin E1-analogue during initial period of experimental gastric ulcer reverses increase in future ulcer relapse caused by indomethacin. Gastroenterology 106(4 Suppl): A41
Schlegel, W.; Wintergalen, N. 1997: Prostaglandin E2 9-reductase from corpus luteum of pseudopregnant rabbit and its identification with 20-alpha-hydroxy-steroid dehydrogenase. FASEB Journal 11(9): A881
Mermoud, A.; Pararajasegaram, G.; Krishna, R.; Baerveldt, G.; Minckler, D.S.; Rao, N.A. 1994: Prostaglandin E2 and F2-alpha in the rat uveitic glaucoma model. IOVS Investigative Ophthalmology and Visual Science 35(4): 1854
Fujimoto, N.; Zhao, C.; Shichi, H. 1995: Prostaglandin E2 and F2-alpha receptors in porcine ciliary muscle. IOVS Investigative Ophthalmology and Visual Science 36(4): S594
Kharitoinov, S.A.; Sapienza, M.A.; Barnes, P.J.; Chung, K.F. 1998: Prostaglandin E2 and F2alpha reduce exhaled nitric oxide in asthmatic and normal subjects irrespective of airway calibre changes. European Respiratory Journal 12(Suppl 28): 364S-365S
Waite, K.J.; Vasko, M.R. 1992: Prostaglandin E2 and elevation of intracellular cyclic AMP enhance bradykinin-stimulated release of peptides from rat sensory neurons in culture. Society for Neuroscience Abstracts 18(1-2): 690
Leppert, D.; Hauser, S.L.; Kishiyama, J.L.; An, S.; Zeng, L.; Goetzl, E.J. 1995: Prostaglandin E2 and leukotriene B4 stimulation of matrix metalloproteinase -dependent T cell migration across a model basement membrane. FASEB Journal 9(4): A853
Bonzel, K.E.; Schwandner, D.; Seyberth, H.W.; Meyer Schwickerath, M.; Kroepfl, D.; Lettgen, B.; Rascher, W. 1992: Prostaglandin E2 and thromboxane B2 excretion in children after pyeloplasty Comparison of the compromised and the non-compromised kidney. Pediatric Nephrology 6(5): C117
Sullivan, T.D.; Kunkel, S.L.; Burdick, M.D.; Glass, M.C.; Arenberg, D.A.; Digiovine, B.; Morris, S.B.; Strieter, R.M. 1996: Prostaglandin E2 augments the production of two pro-inflammatory chemokines. FASEB Journal 10(6): A1485
Laszlo, D.; Bosi, A.; Azzi, A.; De Santis, R.; Fanci, R.; Guidi, S.; Saccardi, R.; Vannucchi, A.M.; Lombardini, L.; Longo, G.; Rossi Ferrini, P. 1994: Prostaglandin E2 bladder instillation for the treatment of BK virus associated hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1994(PROGRAM ABSTR ): 120
Machida, K.; Nonoguchi, H.; Yamakawa, K.; Kitamura, K.; Tomita, K. 1998: Prostaglandin E2 downregulates vasopressin V2 receptor in rat inner medullary collecting ducts in dehydration. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 22A
Shah, T.; Hamilton, R.; Lichtenstein, L.; Macdonald, S. 1993: Prostaglandin E2 enhances immunoglobulin production by a cyclic AMP-independent mechanism in human peripheral blood mononuclear cells. Journal of Allergy and Clinical Immunology 91(1 Part 2): 185
Williams, M.A.; Hickok, D.E.; Zingheim, R.W.; Luthy, D.A. 1994: Prostaglandin E2 gel prior to induction of labor in women with a previous cesarean section. American Journal of Obstetrics and Gynecology 170(1 Part 2): 343
Roszkowski, M.T.; Swift, J.O.; Alton, T.; Hargreaves, K.M. 1992: Prostaglandin E2 immunoreactivity is released during inflammation of the rabbit TMJ. Society for Neuroscience Abstracts 18(1-2): 690
Zahner, G.; Mueller, E.; Harendza, S.; Wolf, G.; Thaiss, F.; Stahl, R.A.K. 1995: Prostaglandin E2 increases mRNA levels and transcription of a 72 kDa matrix-metallo-proteinase in rat mesangial cells in culture. Journal of the American Society of Nephrology 6(3): 916
Won, J.S.; Kim, Y.H.; Song, D.K.; Huh, S.O.; Suh, H.W. 1997: Prostaglandin E2 increases the proenkephalin mRNA level in rat glial cells Role of proto-oncogenes. KOREAN SOCIETY OF PHARMACOLOGY Symposium on Current Topics in Pharmacology and Toxicology : 106
Dalloul, A.; Mentz, F.; Schmitt, C.; Binet, J.L.; Merle Beral, H. 1996: Prostaglandin E2 induces apoptosis of B-chronic lymphocytic leukemia cells through induction of intracellular cyclic-AMP. Blood 88(10 Suppl 1 Part 1-2): 182B
Varga, F.; Glantschnig, H.; Rumpler, M.; Klaushofer, K. 1995: Prostaglandin E2 induces c-fos mRNA expression in the osteoblastic cell line MC3T3-E1 using the serum responsive element. Bone (New York) 17(6): 575
Norris, J.G.; Benveniste, E.N. 1993: Prostaglandin E2 induction of IL-6 gene expression in astrocytes. Journal of Immunology 150(8 Part 2): 49A
Yakabi, K.; Miyamoto, A.; Nakamura, T. 1995: Prostaglandin E2 inhibits ethanol-induced histamine release from isolated canine gastric mast cells. Gastroenterology 108(4 Suppl): A261
Paliogianni, F.; Balow, J.E.; Boumpas, D.T. 1993: Prostaglandin E2 inhibits interleukin 2 gene transcription by interfering with nuclear factors AP-1 and NF-AT. Journal of Immunology 150(8 Part 2): 111A
Schaefer, D.; Klapproth, H.; Baenkler, H.W. 1998: Prostaglandin E2 inhibits peptido-leukotriene and thromboxane B2 release from human bronchial biopsy specimens. Naunyn-Schmiedeberg's Archives of Pharmacology 357(4): R39
Zelenina, M.; Christensen, B.M.; Nielsen, S.; Aperia, A. 1998: Prostaglandin E2 interaction with arginine vasopressin Effects of aquaporin 2 abundance in membrane and the state of AQP2 phosphorylation. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 29A
Anonymous 1996: Prostaglandin E2 level in gingiva of patients with periodontal diseases by RIA and immunohistochemical study. Molecular Biology of the Cell 7(Suppl ): 149A
Evans, C.B.; Pillai, S.; Goldyne, M.E. 1993: Prostaglandin E2 mediates calcium-induced cornified envelope generation by human keratinocytes. Clinical Research 41(1): 5A
Dey, I.; Chadee, K. 2008: Prostaglandin E2 produced by Entamoeba histolytica binds to EP4 receptors and stimulates interleukin-8 production in human colonic cells. Infection and Immunity 76(11): 5158-5163
Kuratko, C.N.; Becker, S.A.; Lake, C.; Gray, C. 1998: Prostaglandin E2 production and fatty acid composition of colonic lymphocytes is altered by dietary lipids. Proceedings of the American Association for Cancer Research 39: 289
Lo, C.J.; Cryer, H.M. 1995: Prostaglandin E2 production by endotoxin stimulated alveolar macrophages is regulated by phospholipase C pathways. Journal of Trauma 39(1): 171
Schafer, J.A.; Li, L. 1998: Prostaglandin E2 production differs in rat and rabbit cortical collecting ducts , and cultured CCD cells. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 415A
Angel, J.; Berenbaum, F.; Le Denmat, C.; Nevalainen, T.J.; Masliah, J.; Fournier, C. 1994: Prostaglandin E2 production induced by IL-1-beta Phospholipases A2 and cyclooxygenases regulation. Arthritis and Rheumatism 37(9 Suppl): S382
Quintero, E.; Del Rivero, M.; Guth, P.H. 1993: Prostaglandin E2 projects gastric mucosa against acid-back diffusion injury in uremic rats. Gastroenterology 104(4 Suppl): A174
Demeure, C.E.; Yang, L.P.; Desjardins, C.; Delespesse, G. 1997: Prostaglandin E2 promotes the maturation of naive human CD4 T cells into effector cells producing high levels of anti-inflammatory cytokines and low levels of pro-inflammatory cytokines. Journal of Allergy and Clinical Immunology 99(1 Part 2): S302
Shinjo, K.; Stock, J.L.; Taniguchi, K.; Burkhardt, J.; Coffman, T.M.; Ishikawa, T.; Mcneish, J.D. 1998: Prostaglandin E2 receptor EP1 subtype-deficient mice have reduced blood pressure and altered nociceptive pain responses. Society for Neuroscience Abstracts 24(1-2): 396
Stillman, B.; Breyer, M.D.; Breyer, R.M. 1998: Prostaglandin E2 receptor chimeras reveal the importance of the extracellular domains in PGE2 receptor function. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 406A
Zhao, C.; Fujimoto, N.; Shichi, H. 1995: Prostaglandin E2 receptor subtypes in porcine ocular tissues. IOVS Investigative Ophthalmology and Visual Science 36(4): S129
Vetter, A.E.; O'grady, S.M. 1995: Prostaglandin E2 regulates ion transport across cultured porcine endometrial epithelial cells. FASEB Journal 9(3): A304
Mochiki, E.; Haga, N.; Suzuki, H.; Mizumoto, A.; Itoh, Z. 1997: Prostaglandin E2 stimulates motilin release via cholinergic muscarinic pathways in dogs. Gastroenterology 112(4 Suppl): A1173
Choudhry, M.A.; Ahmed, Z.; Amato, L.; Sayeed, M.M. 1997: Prostaglandin E2 suppresses P59FYN kinase activation in T cells. Journal of Leukocyte Biology (Suppl ): 23
Willer, S.S.; Jumblatt, M.M. 1994: Prostaglandin E2 synthesis in a wound closure model of the corneal endothelium. IOVS Investigative Ophthalmology and Visual Science 35(4): 1384
Tsai, S.J.; Wiltbank, M.C. 1997: Prostaglandin F-2a induces distinct gene expression in early and mid-cycle bovine corpora lutea. Biology of Reproduction 56(Suppl 1): 174
Puscas, I.; Coltau, M.; Puscas, C. 1995: Prostaglandin F-2alpha activate carbonic anhydrase I and increase arterial blood pressure , while PGI-2 inhibit CA I and reduce ABP. Gastroenterology 108(4 Suppl): A672
Miller, C.W.; Casimir, D.A.; Ntambi, J.M. 1996: Prostaglandin F-2alpha blocks 3T3-L1 preadipocyte differentiation through an FP receptor-mediated calcium release. FASEB Journal 10(6): A1259
Lerea, L.S.; Carlson, N.G.; Simonato, M.; Morrow, J.D.; Roberts, L.J.; Mcnamara, J.O. 1996: Prostaglandin F-2alpha is required for NMDA receptor-induced transcription of c-fos mRNA in dentate gyrus neurons. Society for Neuroscience Abstracts 22(1-3): 262
Brady, H.A.; Wheeler, M.D.; Behrendt, C.Y. 1995: Prostaglandin F-2alpha levels in equine endometrial tissue procured during anestrus. Journal of Animal Science 73(Suppl 1): 215
Kozawa, O.; Tokuda, H.; Kaida, T.; Matsuno, H.; Niwa, M.; Uematsu, T. 1997: Prostaglandin F-2alpha stimulates interleukin-6 synthesis via activation of protein kinase C in osteoblast-like cells. Japanese Journal of Pharmacology 73(Suppl 1): 225P
Li, J.; Gilmour, B.P.; Mcnamara, J.O. 1997: Prostaglandin F-2alpha synthesis induced by kindled seizure. Society for Neuroscience Abstracts 23(1-2): 2161
Schwartz, J.R.; Beck, M.M.; Brown, T.M.; Teruyama, R.; Mahmoud, K.; Forman, M.; Gross, T.S. 1994: Prostaglandin F-2alpha, arginine vasotocin, progesterone production by granulosa cells of heat stressed hens under different protocols. Poultry Science 73(Suppl 1): 33
Kurata, R.; Hisayama, T.; Takayanagi, I. 1993: Prostaglandin F-2alpha-induced calcium release from calcium store and sustained contraction in calcium-free media are mediated by distinct receptor types in rat aorta. Japanese Journal of Pharmacology 61(Suppl 1): 120P
Liang, Z.; Sooranna, S.R.; Engineer, N.; Tattersall, M.; Khanjani, S.; Bennett, P.R.; Myatt, L.; Johnson, M.R. 2008: Prostaglandin F2-alpha receptor regulation in human uterine myocytes. Molecular Human Reproduction 14(4): 215-223
Serrero, G.; Lepak, N.M. 1994: Prostaglandin F2-alpha stimulates TGF-alpha expression in adipocyte precursors in primary culture. International Journal of Obesity 18(Suppl 2): 127
Kulkarni, P.S. 1995: Prostaglandin F2a-vasoconstriction of bovine retinal microcirculation is via thromboxane receptors. IOVS Investigative Ophthalmology and Visual Science 36(4): S137
Sagara, T.; Gaton, D.D.; Lindsey, J.D.; Gabelt, B.T.; Kaufman, P.L.; Weinreb, R.N. 1998: Prostaglandin F2alpha alters extracellular matrix collagens in ciliary muscle, iris root and sclera of monkey eyes in vivo. IOVS Investigative Ophthalmology and Visual Science 39(4): S803
Chen, D.B.; Fong, H.W.; Davis, J.S. 1998: Prostaglandin F2alpha increases c-fos and c-jun mRNA and stimulates the activator protein-1 transcription factors in bovine luteal cells. Biology of Reproduction 58(Suppl 1): 113
Ntambi, J.M. 1998: Prostaglandin F2alpha is a potent inhibitor of 3T3-L1 preadipocyte differentiation. FASEB Journal 12(4): A515
Uenoyama, Y.; Skarzynski, D.J.; Noshita, H.; Okuda, K. 1998: Prostaglandin F2alpha secretion by cultured bovine endometrial cells in response to noradrenaline. Biology of Reproduction 58(Suppl 1): 195
Aten, R.F.; Kolodecik, T.R.; Rossi, M.J.; Debusscher, C.; Behrman, H.R. 1998: Prostaglandin f2alpha treatment in vivo, but not in vitro, stimulates protein kinase C-activated superoxide production by nonsteroidogenic cells of the rat corpus luteum. Biology of Reproduction 59(5): 1069-1076
Tsai, S.J.; Wiltbank, M.C. 1997: Prostaglandin F2alpha upregulates monocyte chemoattractant protein-1 mRNA expression in bovine and ovine corpora lutea. Journal of Animal Science 75(Suppl 1): 81
Schneider, A.; Jocks, T.; Zahner, G.; Mueller, E.; Stahl, R.A.K. 1996: Prostaglandin G/H synthase -1 and -2 expression is increased by treatment with indomethacin and selective PGHS-2 inhibitors in the anti Thy-1 antibody induced glomerulo-nephritis in rats. Journal of the American Society of Nephrology 7(9): 1650
Pratico, D.; Fitzgerald, G.A. 1995: Prostaglandin G/H synthase dependent formation of the isoprostane, 8-epi PGF-2-alpha. Circulation 92(8): I303
Schneider, A.; Jocks, T.; Wenzel, U.; Reszka, M.; Stahl, R.A.K. 1996: Prostaglandin G/H synthase inhibitors modulate glomerular MCP-1 mRNA expression in anti Thy-1 antiserum induced glomerulonephritis in rats. Journal of the American Society of Nephrology 7(9): 1720
Liu, J.; Sirois, J. 1997: Prostaglandin G/H synthase-2 is selectively induced in bovine superovulatory follicles. Biology of Reproduction 56(Suppl 1): 117
O'banion, M.K.; Chang, J.W.; Coleman, P.D. 1996: Prostaglandin G/H synthase-2 mRNA expression is decreased in Alzheimers disease brain. Neurobiology of Aging 17(4 Suppl): S146
Garavito, R.M.; Picot, D.; Loll, P.J. 1994: Prostaglandin H synthase. Current Opinion in Structural Biology 4(4): 529-535
Peri, K.; Hardy, P.; Varma, D.R.; Chemtob, S. 1994: Prostaglandin H synthase -2 is a major source of prostaglandins in the newborn but not in the adult pig brain. Pediatric Research 37(4 Part 2): 67A
Thore, C.R.; Busija, D.W. 1995: Prostaglandin H synthase Immunofluorescent localization in cultured neurons. Society for Neuroscience Abstracts 21(1-3): 557
Dunford, H.B.; Bakovic, M. 1995: Prostaglandin H synthase Mechanistic ambiguities. FASEB Journal 9(6): A1485
Varfolomeyev, S.D.; Mevkh, A.T. 1993: Prostaglandin H synthase as a limiting enzyme of prostaglandin synthesis: substrate-induced inactivation as a new kind of enzyme activity regulation. Biotechnology and Applied Biochemistry 17(3): 291-304
Ren, Y.; Kulmacz, R.J. 1993: Prostaglandin H synthase carboxyl-terminus function and topology. FASEB Journal 7(7): A1149
Moore, S.A.; Yoder, E.J.; Rich, G. 1996: Prostaglandin H synthase expression in cultured cerebral endothelium. FASEB Journal 10(3): A585
Schuhmacher, U.; Fischer, B.; Koburg, J.; Degen, G.H. 1994: Prostaglandin H synthase expression in ram seminal vesicle glands in vivo and in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R105
Kanekal, S.; Kehrer, J.P. 1993: Prostaglandin H synthase inhibitors decrease the antineoplastic effect of cyclophosphamide in vivo. FASEB Journal 7(3-4): A690
Zenser, T.; Lakshmi, V.; Hsu, F.; Dehaven, P.; Davis, B. 1998: Prostaglandin H synthase peroxidatic formation of N-hydroxy-N-acetyl-benzidine. Proceedings of the American Association for Cancer Research 39: 123
Munroe, D.G.; Wang, E.Y.; Macintyre, J.P.; Tam, S.S.C.; Lee, D.H.S.; Taylor, G.R.; Zhou, L.; Plante, R.K.; Kazmi, S.M.I.; Beaeuerle, P.A.; Lau, C.Y. 1995: Prostaglandin H synthase-1 defines a NSAID-insensitive reactive oxygen pathway of NF-kB activation. Journal of Cellular Biochemistry Suppl 1995(21A): 255
Higashihara, M.; Song, X.H.; Miyazaki, K.; Koike, Y.; Watanabe, T.; Kurokawa, K.; Asano, S. 1995: Prostaglandin H synthase-1 is a novel marker of mature megakaryocytic and activated monocytic cell lineage. Blood 86(10 Suppl 1): 898A
Hirst, J.J.; Teixeira, F.J.; Zakar, T.; Olson, D.M. 1995: Prostaglandin H synthase-2 expression increases in human gestational tissues with spontaneous labour onset. Reproduction Fertility and Development 7(3): 633-637
Mitchell, C.M.; Johnson, R.F.; Giles, W.B.; Zakar, T. 2008: Prostaglandin H synthase-2 gene regulation in the amnion at labour: histone acetylation and nuclear factor kappa B binding to the promoter in vivo. Molecular Human Reproduction 14(1): 53-59
Saada, J.I.; Valentich, J.D.; Mifflin, R.C.; Powell, D.W. 1998: Prostaglandin H synthase-2 induction by hydroxy-EICOSA-tetraenoic acids in an intestinal subepithelial myofibroblast cell line. Gastroenterology 114(4 Part 2): A1073
Moore, S.A.; Yoder, E.J. 1995: Prostaglandin H synthase-2 is induced in mouse brain following freeze injury. FASEB Journal 9(3): A381
Ramamurthi, R.; Bollineni, J.S. 1993: Prostaglandin H-2 synthase activity in the tissues of freshwater field crab Oziotelphusa senex senex. Indian Journal of Comparative Animal Physiology 11(2): 139-142
Suzuki, H.; Gao, X.P.; Rubinstein, I. 1997: Prostaglandin H-2/thromboxane A-2 receptor antagonism restores endothelium-dependent vasodilation in hamsters with spontaneous hypertension. FASEB Journal 11(3): A39
Hirata, M.; Ushikubi, F.; Narumiya, S. 1995: Prostaglandin i receptor and prostaglandin D receptor. Journal of Lipid Mediators and Cell Signalling 12(2-3): 393-404
Asai, T.; Morizawa, Y.; Yasuda, A.; Yamamoto, T.; Fujitani, B.; Hosoki, K. 1995: Prostaglandin I-2 derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1174(3): 1956-1957
Takizawa, H.; Dellipizzi, A.; Nasjletti, A. 1995: Prostaglandin I-2 mediates the antihypertensive effect of a lipoxygenase inhibitor in rats with angiotensin II-induced hypertension. Hypertension 26(3): 544
Yuhki, K.-I.; Ushikubi, F.; Naraba, H.; Ueno, A.; Kato, H.; Kojima, F.; Narumiya, S.; Sugimoto, Y.; Matsushita, M.; Oh-Ishi, S. 2008: Prostaglandin I2 plays a key role in zymosan-induced mouse pleurisy. Journal of Pharmacology and Experimental Therapeutics 325(2): 601-609
Hirano, T.; Takeuchi, S. 1995: Prostaglandin I-2 prevents pancreatic subcellular redistribution of lysosomal enzyme in rats with caerulein-induced acute pancreatitis. Medical Science Research 23(8): 541-543
Lo, C.J.; Fu, M.; Lo, F.R. 1998: Prostaglandin I2 analogue, iloprost, down regulates mitogen-activated protein kinases of macrophages. Journal of Surgical Research 76(2): 159-164
Fukushima, M.; Kato, T.; Narumiya, S.; Mizushima, Y.; Sasaki, H.; Terashima, Y.; Nishiyama, Y.; Santoro, M.G. 1989: Prostaglandin a and J: antitumor and antiviral prostaglandins. Advances in Prostaglandin Thromboxane and Leukotriene Research 19: 415-418
Lindsey, J.D.; Kashiwagi, K.; Kashiwagi, F.; Weinreb, R.N. 1997: Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow. Survey of Ophthalmology 41(Suppl 2): S53-S59
Tyler, P.C.; Young, R.N.; Rodan, G.A. 1995: Prostaglandin analog for treating osteoporosis. Official Gazette of the United States Patent and Trademark Office Patents 1173(4): 2706-2707
Stjernschantz, J.; Resul, B.; Lake, S.; Ocklind, A.; Selen, G. 1995: Prostaglandin analogues for reduction of the intraocular pressure in glaucoma. Japanese Journal of Pharmacology 67(Suppl 1): 75P
Laursen, L.S.; Havelund, T.; Lauritsen, K.; Madsen, J.R. 1989: Prostaglandin analogues in the treatment of peptic ulcer disease. Ugeskrift for Laeger 151(2): 74-78
Han M L.; Wang Y F.; Zhang R J. 1991: Prostaglandin and endometriosis. International Journal of Gynecology and Obstetrics (ABSTR Suppl): 487
Riese, J.; Kaever, V. 1992: Prostaglandin and leukotriene synthesis in a macrophage hybrid cell line h4 7. Pathobiology 60(Suppl 1): 29
García-Valdecasas, J.C.; Rull, R.; Grande, L.; Fuster, J.; Rimola, A.; Lacy, A.M.; González, F.X.; Cugat, E.; Gimenez, W.; Visa, J. 1994: Prostaglandin and lipoperoxide levels and postoperative liver function in human liver transplantation. Transplantation Proceedings 26(6): 3633-3634
Guarner, C.; Soriano, G. 1993: Prostaglandin and portal hypertension. Prostaglandins Leukotrienes and Essential Fatty Acids 48(3): 203-206
Smith, W.L.; Marnett, L.J.; DeWitt, D.L. 1991: Prostaglandin and thromboxane biosynthesis. Pharmacology and Therapeutics 49(3): 153-179
Peterson, K.B.; Drower, E.J.; Nash, S.A.; Nevins, M.E.; Savage, M.A.; Stapelfeld, A.; Tam, L.L.; Hansen, D.W.Jr 1995: Prostaglandin antagonist analgesics utilizing heterocycles as diacylhydrazide replacements. Abstracts of Papers American Chemical Society 210(1-2): MEDI 69
Morrison, M.S.F.G. 1998: Prostaglandin applicator. Official Gazette of the United States Patent and Trademark Office Patents 1210(3): 2408
Schuhmacher, U.S.; Degen, G.H. 1993: Prostaglandin biosynthesis in ovine seminal vesicle cell cultures Its modulation by dexamethasone, TCDD and serum. Naunyn-Schmiedeberg's Archives of Pharmacology 348(Suppl): R168
Hyslop, S.; De Nucci, G. 1993: Prostaglandin biosynthesis in the microcirculation: regulation by endothelial and non-endothelial factors. Prostaglandins Leukotrienes and Essential Fatty Acids 49(4): 723-760
Ramamurthi, R.; Reddy, B.M.ralidhara 1994: Prostaglandin biosynthesis in the rice field crab Oziotelphusa senex senex. FASEB Journal 8(4-5): A733
Mukhopadhyay, A.; Roy, A.; Lahiri, S.C. 1993: Prostaglandin biosynthesis inhibitory activity of some indian-1 acids in relation to their anti-inflammatory activity and ulcerogenic potency. Indian Journal of Experimental Biology 31(4): 392-394
Kranc, D.M.; Kim, J.; Strauss, F.; Levine, L.A. 1992: Prostaglandin bladder irrigation for treatment of cyclophosphamide induced hemorrhagic cystitis in the rat model. Journal of Urology 147(4 Suppl): 409A
Krunic, N.; Adamson, S.L.; Bishai, I.; Coceani, F. 1996: Prostaglandin catabolism in the fetal choroid plexus A special arrangement. Society for Neuroscience Abstracts 22(1-3): 773
Desantis, L.M.; Sallee, V.L. 1996: Prostaglandin combinations in glaucoma therapy. Official Gazette of the United States Patent and Trademark Office Patents 1191(3): 1975
Osborn, J.F.; Wittenberg, J.M. 1990: Prostaglandin concentrations in femoral rat bone following implantation of hydroxyapatite ceramics and alumina. Heimke, G , U Soltesz And A J C Lee (Ed ) Advances in Biomaterials, Vol 9 Clinical Implant Materials; Eighth European Conference on Biomaterials, Heidelberg, West Germany, September 7-9, 1989 Xvi+676p Elsevier Science Publishers B V : Amsterdam, Netherlands; New York, New York, Usa Illus 249-254
Filley, S.J.; Turner, H.A.; Stormshak, F. 1997: Prostaglandin concentrations in lipid-infused post-partum heifers. Biology of Reproduction 56(Suppl 1): 207
Kostenko, E.V.; Denisova, M.F.; Yakovlev, A.A. 1991: Prostaglandin content in the blood and gastric mucosa in children with functional disorders of the stomach and chronic gastroduodenitis. Pediatriya (Moscow) (1): 21-24
Kmiec, Z. 1994: Prostaglandin cytoprotection of galactosamine-induced hepatocytes isolated from young and old rats. Zs -Nagy, I, Harman, D, Kitani, K Annals of the New York Academy of Sciences; Pharmacology of aging processes: Methods of assessment and potential interventions 216-225
Paller, M.S.; Manivel, J.C.rlos 1992: Prostaglandin cytoprotection of proximal tubule epithelial cells against hypoxia/reoxygenation injury. Journal of the American Society of Nephrology 3(3): 712
Howarth, P.; Walsh, S.; Robinson, C. 1990: Prostaglandin d 2 a mediator of nasal blockage. Journal of Allergy and Clinical Immunology 85(1 Part 2): 223
Coe, J.Y.; Timinsky, J.; Mcgonigle, L.; Philipos, E.; Simmonds, B.; Coceani, F.; Olley, P.M. 1990: Prostaglandin d 2 pgd 2 constricts the pulmonary vasculature in the fetal and one day old piglets. Pediatric Research 27(4 Part 2): 17A
Coe, J.Y.; Timinsky, J.; Phillipos, E.; Coceani, F.; Olley, P.M. 1990: Prostaglandin d 2 pgd 2 is a pulmonary vasoconstrictor in fetal piglets. Clinical and Investigative Medicine 13(5 Suppl): C38
Alafiatayo, R.; Pentreath, V.W. 1992: Prostaglandin d 2 production by cultured mouse fibroblasts induced by trypanosoma brucei brucei products and endotoxin. Annales de la Societe Belge de Medecine Tropicale 72(Suppl 1): 92-93
Bacic, F.; Uematsu, S.; Mccarron, R.M.; Spatz, M. 1991: Prostaglandin d 2 production in human cerebromicrovascular endothelium. Society for Neuroscience Abstracts 17(1-2): 238
Thomas, P.S.; Wilson, A.N.; Lazarus, S.C. 1990: Prostaglandin d 2 release from purified mast cell granules. Clinical Research 38(1): 160A
Kanemura, T.; Tamaoki, J.; Sakai, N.; Isono, K.; Kobayashi, K.; Takizawa, T. 1991: Prostaglandin d 2 stimulates chloride secretion by canine cultured tracheal epithelium via pge 2 and cyclic amp dependent pathway. American Review of Respiratory Disease 143(4 Part 2): A134
Challis, J.; Han, X.; Rossdale, P.; Ousey, J.; Holdstock, N.; Allen, W.; Silver, M.; Fowden, A. 1994: Prostaglandin dehydrogenase and steroidogenic enzymes are localized in different cell types in the equine placenta. Journal of Reproduction and Fertility Abstract Series 1994(14): 6
Akabane, S.; Imanishi, M.; Matsushima, Y.; Kawamura, M.; Kuramochi, M.; Ito, K.; Omae, T. 1989: Prostaglandin dependent and independent renin release in the kidney with renal arterial stenosis. Japanese Journal of Pharmacology 49(Suppl): 297P
Isono, K.; Tamaoki, J.; Kanemura, T.; Sakai, N.; Takizawa, T. 1991: Prostaglandin dependent increase in short circuit current of canine cultured airway epithelium by platelet activating factor. American Review of Respiratory Disease 143(4 Part 2): A152
Schror, K.; Thiermann, T. 1989: Prostaglandin derivatives in the treatment of cardiovascular diseases. Seminars in Thrombosis and Hemostasis 15(2): 235
Narumiya, S.; Hayaishi, O.; Kimura, Y.; Tsuboshima, M. 1989: Prostaglandin derivatives us patent 4812457 march 14 1989. Official Gazette of the United States Patent and Trademark Office Patents 1100(2): 1055
Henley, K.S.; Reynolds, T.B.; Moran, M. 1990: Prostaglandin e 1 analog enisoprost in primary biliary cirrhosis pbc a pilot trial. Hepatology 12(4 Part 2): 955
Kircheis, G.; Prietzsch, P.; Boehme, I.; Gieseler, C.; Mest, H.J.; Nilius, R. 1991: Prostaglandin e 1 and alpha tocopherol induced changes of thromboxane a 2 txa 2 in acute liver injury. Journal of Hepatology 13(Suppl 2): S39
Mayes, J.T.; Robinson, A.R.; Masih, R.; Nguyen T T.; Schulak, J.A. 1991: Prostaglandin e 1 effects on renal reperfusion injury in a chronic model. Surgical Forum 42: 49-51
Yokomori, H.; Oda, M.; Nishida, J.; Inoue, J.; Ishii, K.; Kaneko, H.; Kazemoto, S.; Itoh, K.; Nakamura, M.; Tsuchiya, M. 1991: Prostaglandin e 1 enhances bile flow dynamic and electron microscopic characterization. Japanese Journal of Clinical Electron Microscopy 24(5-6): 615-616
Bearman, S.I.; Hinds, M.S.; Mcdonald, G.B. 1991: Prostaglandin e 1 for the prevention of hepatic venocclusive disease results of a phase i study. Experimental Hematology 19(6): 576
Vogelpohl, M.; Nobbe, F. 1991: Prostaglandin e 1 in the treatment of incomplete ischemia syndromes of the lower extremities. Vasa Suppl (32): 377-382
Vono, M.B.; Tucker, D.C. 1992: Prostaglandin e 1 increases growth of myocardium cultured in oculo. FASEB Journal 6(5): A1600
Park, J.M.; Schmer, V.; Sridaromont, S.; Park, J.W. 1989: Prostaglandin e 1 induced ductal reversal shunt in transposition of the great arteries. Clinical Research 37(1): 41A
Salvatori, R.; Guidon, P.T.; Rapuano, B.E.; Bockman, R.S. 1992: Prostaglandin e 1 inhibits collagenase gene expression in rabbit synoviocytes via cyclic adenosine 3 5 monophosphate. Clinical Research 40(2): 224A
Sen, H.A.; Campochiaro, P.A. 1990: Prostaglandin e 1 mimics the effects of adenosine agonists on the retinal vasculature. IOVS Investigative Ophthalmology and Visual Science 31(4): 139
Mihas, A.A.; Subramony, C.; Markov, A.K. 1991: Prostaglandin e 1 misoprostol attenuates the carbon tetrachloride induced damage in the rat. Gastroenterology 100(5 Part 2): A774
Doerr, T.A.; Rosolia, D.L.; Gee, M.H.; Albertine, K.H. 1990: Prostaglandin e 1 pge 1 infusion is associated with decreased attachment of neutrophils pmns to air emboli in vivo during complement induced acute lung injury. Anatomical Record 226(4): 27A
Longenecker, G.; Beyers, B. 1991: Prostaglandin e 1 pge 1 inhibition of sickle red blood cell rbc endothelium adhesion. FASEB Journal 5(4): A500
Cattell, V.; Smith, J.; Cook, T. 1989: Prostaglandin e 1 pge 1 suppresses macrophage infiltration and ameliorates injury in accelerated nephrotoxic nephritis acc ntn. Nephrology Dialysis Transplantation 4(9): 836
Raja, S.N.; Mitzel, E.L.; Campbell, J.N. 1990: Prostaglandin e 1 sensitizes cutaneous nociceptors in monkey. Society for Neuroscience Abstracts 16(1): 415
Wolff, L.; Koller, R.; Nason Burchenal, K. 1990: Prostaglandin e 2 abrogates the inhibitory effects of indomethacin on promonocytic tumor formation. Experimental Hematology 18(6): 640
Nicol, G.D.; Vasko, M.R. 1991: Prostaglandin e 2 activates calcium currents in dorsal root ganglion neurons. Biophysical Journal 59(2 Part 2): 84A
Siemer, C.; Goegelein, H. 1991: Prostaglandin e 2 activates nonselective cation channels in basal crypt cells from rat distal colon. Pfluegers Archiv European Journal of Physiology 418(Suppl 1): R70
Hayashi, H.; Eguchi, N.; Urade, Y.; Ito, S.; Hayaishi, O. 1989: Prostaglandin e 2 administered intravenously crosses the blood brain barrier and induces hyperthermia as a central action. Barkai, A I And N G Bazan (Ed ) Annals Of The New York Academy Of Sciences, Vol 559 Arachidonic Acid Metabolism in The Nervous System: Physiological And Pathological Significance; Conference, Bethesda, Maryland, Usa, April 14-16, 1988 Xii+504p New York Academy Of Sciences: New York, New York, Usa Illus 451-452
Adcock, J.J.; Higenbottam, T.W.; Mohammed, S.P. 1991: Prostaglandin e 2 aerosol causes stimulation of lung irritant receptors in anesthetized cats. Journal of Physiology (Cambridge) 432: 39P
Karck, U.; Peters, T.; Decker, K. 1989: Prostaglandin e 2 and dexamethasone are involved in the regulation of tumor necrosis factor release by endotoxin stimulated rat kupffer cells. Experimental Cell Biology 57(2): 101
Cishek, M.B.; Sprague, R.S.; Stephenson, A.H.; Wurtz, M.M.; Weintraub, N.L.; Lonigro, A.J. 1992: Prostaglandin e 2 and f 2 alpha induced contractions of canine pulmonary veins are mediated through a thromboxane endoperoxide receptor. FASEB Journal 6(4): A1181
Bachelet, M.; Masliah, J.; Malanchere, E.; Lefort, J.; Bereziat, G.; Vargaftig, B.B. 1989: Prostaglandin e 2 and salbutamol are less effective in raising cyclic amp levels of alveolar macrophages from ovalbumin sensitized guinea pigs as compared to controls. Agents and Actions 26(1-2): 103-104
Coceani, F.; Bishai, I.; Hynes, N.; Lees, J.; Sirko, S. 1989: Prostaglandin e 2 as a central messenger of fever mechanism of formation. Zor, U , Z Noar And A Danon (Ed ) New Trends in Lipid Mediators Research, Vol 3 Leukotrienes And Prostanoids in Health And Disease; 2nd International Conference, Jerusalem, Israel, October 9-14, 1988 X+345p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 183-186
Matsumura, K.; Kanosue, K.; Watanabe, Y.; Onoe, H.; Koyama, Y.; Watanabe, Y. 1990: Prostaglandin e 2 binding sites in rat hypothalamus. Japanese Journal of Physiology 40(Suppl): S277
Bhattacherjee, P.; Csukas, S.; Paterson, C.A. 1989: Prostaglandin e 2 binding sites in the iris ciliary body of bovine eyes. IOVS Investigative Ophthalmology and Visual Science 30(3): 269
Mosleth, M.B.; Funahashi, A.; Lefever, A. 1991: Prostaglandin e 2 content in bronchoalveolar lavage fluid in patients with bronchogenic carcinoma. American Review of Respiratory Disease 143(4 Part 2): A203
Christman, B.W.; Christman, J.W. 1990: Prostaglandin e 2 decreases leukotriene b 4 production by a 23187 stimulated rat alveolar macrophages analysis by gas chromatography mass spectrometry. American Review of Respiratory Disease 141(4 Part 2): A393
Betz, M.; Fox, B.S. 1990: Prostaglandin e 2 differentially regulates il 2 and il 4 production. FASEB Journal 4(7): A1770
Hagel Bradway, S.; Dziak, R. 1989: Prostaglandin e 2 effects in osteoblastic cells role of protein kinase c and g proteins. Journal of Dental Research 68(Special Issue): 354
Labar, B.; Pavletic, Z.; Bogdanic, V.; Nemet, D.; Aurer, I.; Jakic, J. 1990: Prostaglandin e 2 for prevention of oral mucositis in patients with leukemia undergoing bone marrow transplantation a randomized double blind clinical trial. Experimental Hematology 18(6): 700
Hempel, S.L.; Wessels, D.A.; Spector, A.A. 1991: Prostaglandin e 2 formation following oxidant stress is dependent on glutathione. Clinical Research 39(2): 185A
Elsner, D.; Muentze, A.; Riegger, G.A.J. 1990: Prostaglandin e 2 in dogs with heart failure hemodynamic renal and hormonal effects. Circulation 82(4 Suppl 3): III489
Plotquin, D.; Katz, S.; Danon, A.; Dekel, S. 1989: Prostaglandin e 2 in human osteomyelitis. Calcified Tissue International 44(Suppl): S36
Van Haeringen, N.J.; Van Delft, J.L.; Oosterhuis, J.A. 1989: Prostaglandin e 2 in the vitreous humor of the rabbit. International Ophthalmology 13(Suppl): 459
John, A.; Mohler, D.G.; Lane, J.M.; Healy, J.H.; Huber, B.; Ullman, T.A. 1989: Prostaglandin e 2 increase hexosamine content in early fracture callus an experimental study in the rat. Calcified Tissue International 44(Suppl): S2
Tatakis, D.N.; Dziak, R. 1989: Prostaglandin e 2 increases cytosolic calcium in osteoblastic osteosarcoma cells. Journal of Dental Research 68(Special Issue): 258
Bednarcyzk, B.; Padeh, S.; Roifman, C.M. 1990: Prostaglandin e 2 increases phosphoinositol turnover and induces desensitization of sig receptor in b cell. FASEB Journal 4(3): A338
Padeh, S.; Bednarczyk, B.; Roifman, C.M. 1992: Prostaglandin e 2 increases phosphoinositol turnover and induces desensitization of the sig receptor in b cells. Journal of Rheumatology 19(Suppl 33): 115
Cishek, M.E.; Sprague, R.S.; Stephenson, A.H.; Wurtz, M.M.; Weintraub, N.L.; Lonigro, A.J. 1991: Prostaglandin e 2 induced contractions of canine pulmonary veins are mediated through the thromboxane endoperoxide receptor. Clinical Research 39(3): 751A
Ikeda, S.R. 1989: Prostaglandin e 2 inhibits a calcium current in adult rat superior cervical ganglion scg neurons. Society for Neuroscience Abstracts 15(2): 1149
Giembycz, M.A.; Kroegel, C.; Barnes, P.J. 1990: Prostaglandin e 2 inhibits platelet activating factor induced eosinophil activation. American Review of Respiratory Disease 141(4 Part 2): A396
Mahl, T.C.; Tzung S P.; Lance, P.; Anderson, V.; Cohen, S.A. 1992: Prostaglandin e 2 inhibits tumor necrosis factor production by kupffer cells and prevents endotoxin induced mortality in mice. Gastroenterology 102(4 Part 2): A846
Matsumura, K.; Uchida, J.; Kanosue, K.; Tanaka, H.; Onoe, H.; Watanabe, Y. 1991: Prostaglandin e 2 level in the rat brain after intravenous injection of bacterial endotoxin. Japanese Journal of Physiology 41(Suppl): S331
Ikeda, S.R. 1992: Prostaglandin e 2 modulates an n type calcium channel in adult rat sympathetic neurons via a guanine nucleotide binding protein. Biophysical Journal 61(2 Part 2): A398
Frazier, L.W. 1992: Prostaglandin e 2 pge 2 and metabolic acidosis ma stimulates intracellular free calcium in isolated cells of toad urinary bladder. FASEB Journal 6(5): A1766
Ohnishi, H.; Lin, T.H.; Nakajima, I.; Chu, T.M. 1991: Prostaglandin e 2 pge 2 from macrophages of murine splenocyte cultures inhibits generation of lymphokine activated lak killer cell activity. FASEB Journal 5(4): 638
Hebert, R.L.; Jacobson, H.; Breyer, M. 1989: Prostaglandin e 2 pge 2 increases intracellular calcium in rabbit collecting ducts ccd. FASEB Journal 3(4): A978
Long, C.; Kinoshita, Y.; Knox, F.G. 1990: Prostaglandin e 2 pge 2 induced changes in renal blood flow rbf renal interstitial hydrostatic pressure rihp and sodium excretion in the rat. FASEB Journal 4(4): A1125
Ling, B.N.; Kokko, K.E.; Eaton, D.C. 1991: Prostaglandin e 2 pge 2 inhibits apical sodium channels in rabbit cortical collecting tubules cct via protein kinase c pkc. Journal of the American Society of Nephrology 2(3): 744
Kaji, D. 1991: Prostaglandin e 2 pge 2 inhibits sodium potassium chloride 2 cotransport in cultured mouse medullary thick ascending limb mtal cells. Journal of the American Society of Nephrology 2(3): 428
Moylan, R.D.; Roche, J.K. 1991: Prostaglandin e 2 pge 2 modulation of activation driven t cell death implications for chronic inflammatory states. Gastroenterology 100(5 Part 2): A601
Ligumsky, M.; Delvalle, J.; Park, J.; Yamada, T. 1990: Prostaglandin e 2 pge 2 potentiates cck induced and gastrin induced release of somatostatin like immunoreactivity sli from canine gastric d cells. Gastroenterology 98(5 Part 2): A506
Pueringer, R.J.; Hunninghake, G.W. 1990: Prostaglandin e 2 pge 2 production by human alveolar macrophages requires new synthesis of cyclooxygenase. American Review of Respiratory Disease 141(4 Part 2): A133
Fritsche, K.L.; Bienhoff, S.E.; Allen, G.A.; Berg, J.N. 1991: Prostaglandin e 2 pge 2 production from bovine alveolar macrophages stimulated with bovine respiratory viruses and bacterial endotoxins. FASEB Journal 5(5): A1272
Mccarthy, T.L.; Canalis, E.; Centrella, M. 1991: Prostaglandin e 2 pge 2 regulates insulin like growth factor igf i an dii binding in primary preosteoblastic cell cultures isolated from fetal rat canalis. Journal of Cell Biology 115(3 Part 2): 221A
Weintraub, N.L.; Sprague, R.S.; Stephenson, A.H.; Wurtz, M.M.; Cishek, M.E.; Lonigro, A.J. 1991: Prostaglandin e 2 preferentially increases pulmonary venous resistance in the isolated perfused canine lung. Clinical Research 39(3): 708A
Ballard, H.J.; Achike, F.I. 1992: Prostaglandin e 2 produces presynaptic inhibition of carotid baroreflex induced vasoconstriction in skeletal muscle of anaesthetized dogs. Journal of Physiology (Cambridge) 452: 12P
Konda, Y.; Sakamoto, C.; Nishisaki, H.; Nakano, O.; Matsuda, K.; Wada, K.; Matozaki, T.; Suzuki, T.; Nagao, M.; Kasuga, M. 1991: Prostaglandin e 2 protects isolated guinea pig chief cells against ethanol injury via an increase in diacylglycerol. Gastroenterology 100(5 Part 2): A100
Fiorucci, S.; Mcarthur, K.E. 1990: Prostaglandin e 2 rapidly desensitized pepsinogen secretion in isolated chief cells. Gastroenterology 98(5 Part 2): A44
W.W.ng C Y.; Yao, P.; Wang S L.; Slomiany, A.; Slomiany, B.L. 1991: Prostaglandin e 2 receptor in submandibular glands. Journal of Dental Research 70(Special Issue): 314
Cameron, G.S.; Stadig, B.K.; Fischer, S.M. 1992: Prostaglandin e 2 receptors and the effects of phorbol ester on prostaglandin e 2 binding in cultured mouse keratinocytes. Journal of Investigative Dermatology 98(4): 640
Cameron, G.S.; Stadig, B.K.; Fischer, S.M. 1992: Prostaglandin e 2 receptors and the effects of phorbol ester on prostaglandin e 2 binding in cultures mouse keratinocytes. Clinical Research 40(2): 511A
Shaw, B.R.; Weinreb, R.N. 1989: Prostaglandin e 2 release in human anterior segment organ culture. IOVS Investigative Ophthalmology and Visual Science 30(3): 355
Young, M.R.; Young, M.E.; Duffie, G.P. 1989: Prostaglandin e 2 responsiveness of lewis lung carcinoma variants. Proceedings of the American Association for Cancer Research 30: 87
Ahrenstedt, O.; Knutson, L.; Hallgren, R. 1990: Prostaglandin e 2 secretion in jejunum in crohns disease. Gastroenterology 98(5 Part 2): A155
Ren, J.; Benishin, C.G. 1991: Prostaglandin e 2 selectively inhibits calcium activated potassium channels in rat brain synaptosomes. Society for Neuroscience Abstracts 17(1-2): 958
Young, M.R.I.; Young, M.E.; Wright, M.A. 1991: Prostaglandin e 2 stimulated metastasis mechanisms for hyperactivation protein kinase a in metastatic vs nonmetastatic lewis lung carcinoma clones. Proceedings of the American Association for Cancer Research 32: 67
Parrish, A.; Petzel, D.; Stanley Samuelson, D. 1992: Prostaglandin e 2 stimulates increased intracellular camp concentrations in malpighian tubules of the yellow fever mosquito aedes aegypti. FASEB Journal 6(5): A1747
Bry, K.; Hallman, M. 1990: Prostaglandin e 2 stimulating activity from human neutrophils. Pediatric Research 27(4 Part 2): 200A
Bhatnagar, S.; Meaney, M.J.; Amir, S. 1990: Prostaglandin e 2 stimulation of brown adipose tissue bat thermogenesis in spontaneously hypertensive shr and wky rats. Society for Neuroscience Abstracts 16(2): 1203
Goodman, S.B.; Chin, R.C.; Chiou, S.S.; Lee, J.S. 1992: Prostaglandin e 2 synthesis by the tissue surrounding ultrahigh molecular weight polyethylene in different physical forms. St John, K R (Ed ) Astm (American Society For Testing And Materials) Special Technical Publication, No 1144 Particulate Debris From Medical Implants: Mechanisms Of Formation And Biological Consequences; Symposium on Biocompatibility Of Particulate Implant Materials, San Antonio, Texas, Usa, October 31, 1990 Vi+211p American Society For Testing And Materials: Philadelphia, Pennsylvania, Usa Illus Paper 111-117
Davis, B.H.; Beno, D.W.A. 1990: Prostaglandin e and precursor fatty acids differentially modulate ito cell pdgf response collagen expression and raf activation. Hepatology 12(4 Part 2): 932
Pogrzeba, B.; Luedtke, F.E.; Mandrek, K.; Golenhofen, K.; Lepsien, G. 1990: Prostaglandin e effects indicate a specialized sphincteric function of porcine ileocecal junction in vitro. Digestion 46(Suppl 1): 88
Martin, S.M.; Malkinson, T.J.; Veale, W.L.; Pittman, O.J. 1991: Prostaglandin e induced fever during estrus cycle in the rat. Society for Neuroscience Abstracts 17(1-2): 836
Ertl, R.F.; Valenti, V.; Spurzem, J.R.; Kawamoto, M.; Nakamura, Y.; Veys, T.; Allegra, L.; Romberger, D.J.; Rennard, S.I. 1992: Prostaglandin e inhibits fibroblast recruitment. American Review of Respiratory Disease 145(4 Part 2): A19
Heerdt, P.M. 1990: Prostaglandin e nitroprusside and pulmonary blood flow distribution during one lung ventilation in the dog. Anesthesiology 73(3A): A599
Roper, R.L.; Conrad, D.H.; Brown, D.M.; Warner, G.L.; Phipps, R.P. 1991: Prostaglandin e promotes il 4 induced class switching to ige and igg1. Journal of Cellular Biochemistry Suppl (15 Part F): 79
Mion, F.; Johnston, D.E. 1990: Prostaglandin e synthesis in rat hepatocytes homogenates. Gastroenterology 98(5 Part 2): A609
D.S.rvi S.; Klugman, S.; Chioin, R.; Barbieri, E.; Sperandeo, A. 1990: Prostaglandin e1 administration in unstable angina patients undergoing ptca preliminary results. European Heart Journal 11(ABSTR Suppl): 378